[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 3393 Reported in Senate (RS)]
<DOC>
Calendar No. 319
118th CONGRESS
2d Session
S. 3393
To reauthorize the SUPPORT for Patients and Communities Act, and for
other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
December 4, 2023
Mr. Sanders (for himself and Mr. Cassidy) introduced the following
bill; which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
February 1, 2024
Reported by Mr. Sanders, with an amendment
[Strike out all after the enacting clause and insert the part printed
in italic]
_______________________________________________________________________
A BILL
To reauthorize the SUPPORT for Patients and Communities Act, and for
other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
<DELETED>SECTION 1. SHORT TITLE; TABLE OF CONTENTS.</DELETED>
<DELETED> (a) Short Title.--This Act may be cited as the ``SUPPORT
for Patients and Communities Reauthorization Act''.</DELETED>
<DELETED> (b) Table of Contents.--The table of contents for this Act
is as follows:</DELETED>
<DELETED>Sec. 1. Short title; table of contents.
<DELETED>TITLE I--PREVENTION
<DELETED>Sec. 101. First responder training program.
<DELETED>Sec. 102. Surveillance and education regarding infections
associated with illicit drug use and other
risk factors.
<DELETED>Sec. 103. Preventing overdoses of controlled substances.
<DELETED>Sec. 104. Pilot program for public health laboratories to
detect fentanyl and other synthetic
opioids.
<DELETED>Sec. 105. Prenatal and postnatal health.
<DELETED>Sec. 106. Donald J. Cohen National Child Traumatic Stress
Initiative.
<DELETED>Sec. 107. Surveillance and data collection for child, youth,
and adult trauma.
<DELETED>Sec. 108. Preventing adverse childhood experiences.
<DELETED>Sec. 109. Clarification of use of funds for products used to
prevent overdose deaths.
<DELETED>Sec. 110. Support for individuals and families impacted by
fetal alcohol spectrum disorder.
<DELETED>Sec. 111. Promoting State choice in PDMP systems.
<DELETED>TITLE II--TREATMENT
<DELETED>Sec. 201. Residential treatment program for pregnant and
postpartum women.
<DELETED>Sec. 202. Loan repayment program for substance use disorder
treatment workforce.
<DELETED>Sec. 203. Regional centers of excellence in substance use
disorder education.
<DELETED>Sec. 204. Mental and behavioral health education and training
program.
<DELETED>Sec. 205. Grants to enhance access to substance use disorder
treatment.
<DELETED>Sec. 206. Grants to improve trauma support services and mental
health care for children and youth in
educational settings.
<DELETED>Sec. 207. Development and dissemination of model training
programs for substance use disorder patient
records.
<DELETED>Sec. 208. Task force on best practices for trauma-informed
identification, referral, and support.
<DELETED>Sec. 209. Program to support coordination and continuation of
care for drug overdose patients.
<DELETED>Sec. 210. Regulations relating to special registration for
telemedicine.
<DELETED>Sec. 211. Mental health parity.
<DELETED>Sec. 212. State guidance related to individuals with serious
mental illness and children with serious
emotional disturbance.
<DELETED>Sec. 213. Improving access to addiction medicine providers.
<DELETED>TITLE III--RECOVERY
<DELETED>Sec. 301. Youth prevention and recovery.
<DELETED>Sec. 302. Comprehensive opioid recovery centers.
<DELETED>Sec. 303. Building communities of recovery.
<DELETED>Sec. 304. Peer support technical assistance center.
<DELETED>Sec. 305. CAREER Act.
<DELETED>Sec. 306. Office of recovery.
<DELETED>TITLE IV--TECHNICAL AMENDMENTS
<DELETED>Sec. 401. Delivery of a controlled substance by a pharmacy to
an administering practitioner.
<DELETED>Sec. 402. Technical correction on controlled substances
dispensing.
<DELETED>Sec. 403. Required training for prescribers of controlled
substances.
<DELETED>TITLE I--PREVENTION</DELETED>
<DELETED>SEC. 101. FIRST RESPONDER TRAINING PROGRAM.</DELETED>
<DELETED> Section 546 of the Public Health Service Act (42 U.S.C.
290ee-1) is amended--</DELETED>
<DELETED> (1) in subsection (a), by striking ``tribes and
tribal'' and inserting ``Tribes and Tribal'';</DELETED>
<DELETED> (2) in subsections (a), (c), and (d)--</DELETED>
<DELETED> (A) by striking ``approved or cleared''
each place it appears and inserting ``approved,
cleared, or otherwise legally marketed''; and</DELETED>
<DELETED> (B) by striking ``opioid'' each place it
appears;</DELETED>
<DELETED> (3) in subsection (f)--</DELETED>
<DELETED> (A) by striking ``approved or cleared''
each place it appears and inserting ``approved,
cleared, or otherwise legally marketed'';</DELETED>
<DELETED> (B) in paragraph (1), by striking
``opioid'';</DELETED>
<DELETED> (C) in paragraph (2)--</DELETED>
<DELETED> (i) by striking ``opioid and
heroin'' and inserting ``opioid, heroin, and
other drug''; and</DELETED>
<DELETED> (ii) by striking ``opioid
overdose'' and inserting ``overdose'';
and</DELETED>
<DELETED> (D) in paragraph (3), by striking ``opioid
and heroin''; and</DELETED>
<DELETED> (4) in subsection (h), by striking ``$36,000,000
for each of fiscal years 2019 through 2023'' and inserting
``$56,000,000 for each of fiscal years 2024 through
2028''.</DELETED>
<DELETED>SEC. 102. SURVEILLANCE AND EDUCATION REGARDING INFECTIONS
ASSOCIATED WITH ILLICIT DRUG USE AND OTHER RISK
FACTORS.</DELETED>
<DELETED> Section 317N(d) of the Public Health Service Act (42
U.S.C. 247b-15(d)) is amended by striking ``2019 through 2023'' and
inserting ``2024 through 2028''.</DELETED>
<DELETED>SEC. 103. PREVENTING OVERDOSES OF CONTROLLED
SUBSTANCES.</DELETED>
<DELETED> Section 392A of the Public Health Service Act (42 U.S.C.
280b-1) is amended--</DELETED>
<DELETED> (1) in subsection (a)--</DELETED>
<DELETED> (A) in paragraph (2)--</DELETED>
<DELETED> (i) in subparagraph (C), by
inserting ``and associated risks'' before the
period at the end; and</DELETED>
<DELETED> (ii) in subparagraph (D), by
striking ``opioids'' and inserting ``substances
causing overdose'';</DELETED>
<DELETED> (B) in paragraph (3)(A)--</DELETED>
<DELETED> (i) by inserting ``identify
substances causing overdose and'' after
``rapidly''; and</DELETED>
<DELETED> (ii) by striking ``abuse, and
overdoses'' and inserting ``overdoses, and
associated risk factors'';</DELETED>
<DELETED> (2) in subsection (b)(2)--</DELETED>
<DELETED> (A) in subparagraph (B), by inserting ``,
and associated risk factors,'' after ``such
overdoses'';</DELETED>
<DELETED> (B) in subparagraph (C), by striking
``coding'' and inserting ``monitoring and
identifying'';</DELETED>
<DELETED> (C) in subparagraph (E)--</DELETED>
<DELETED> (i) by inserting a comma after
``public health laboratories''; and</DELETED>
<DELETED> (ii) by inserting ``and other
emerging substances related'' after
``analogues''; and</DELETED>
<DELETED> (D) in subparagraph (F,) by inserting
``and associated risk factors'' after ``overdoses'';
and</DELETED>
<DELETED> (3) in subsection (e) by striking ``$496,000,000
for each of fiscal years 2019 through 2023'' and inserting
``$505,579,000 for each of fiscal years 2024 through
2028''.</DELETED>
<DELETED>SEC. 104. PILOT PROGRAM FOR PUBLIC HEALTH LABORATORIES TO
DETECT FENTANYL AND OTHER SYNTHETIC OPIOIDS.</DELETED>
<DELETED> Section 7011 of the SUPPORT for Patients and Communities
Act (42 U.S.C. 247d-10 note) is amended by striking subsection
(d).</DELETED>
<DELETED>SEC. 105. PRENATAL AND POSTNATAL HEALTH.</DELETED>
<DELETED> Section 317L(d) of the Public Health Service Act (42
U.S.C. 2476b-13(d)) is amended by striking ``2019 through 2023'' and
inserting ``2024 through 2028''.</DELETED>
<DELETED>SEC. 106. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS
INITIATIVE.</DELETED>
<DELETED> Section 582 of the Public Health Service Act (42 U.S.C.
290hh-1) is amended--</DELETED>
<DELETED> (1) in the section heading, by striking ``violence
related stress'' and inserting ``traumatic events'';</DELETED>
<DELETED> (2) in subsection (a)--</DELETED>
<DELETED> (A) in the matter preceding paragraph (1),
by striking ``tribes and tribal'' and inserting
``Tribes and Tribal''; and</DELETED>
<DELETED> (B) in paragraph (2), by inserting ``and
dissemination'' after ``the development'';</DELETED>
<DELETED> (3) in subsection (b), by inserting ``and
dissemination'' after ``the development'';</DELETED>
<DELETED> (4) in subsection (d)--</DELETED>
<DELETED> (A) by striking ``The NCTSI'' and
inserting the following:</DELETED>
<DELETED> ``(1) Coordinating center.--The NCTSI'';
and</DELETED>
<DELETED> (B) by adding at the end the
following:</DELETED>
<DELETED> ``(2) NCTSI grantees.--In carrying out subsection
(a)(2), NCTSI grantees shall develop trainings and other
resources, as applicable and appropriate, to support
implementation of the evidence-based practices developed and
disseminated under such subsection.'';</DELETED>
<DELETED> (5) in subsection (e)--</DELETED>
<DELETED> (A) by redesignating paragraphs (1) and
(2) as subparagraphs (A) and (B), respectively, and
adjusting the margins accordingly;</DELETED>
<DELETED> (B) in subparagraph (A), as so
redesignated, by inserting ``and implementation'' after
``the dissemination'';</DELETED>
<DELETED> (C) by striking ``The NCTSI'' and
inserting the following:</DELETED>
<DELETED> ``(1) Coordinating center.--''; and</DELETED>
<DELETED> (D) by adding at the end the
following:</DELETED>
<DELETED> ``(2) NCTSI grantees.--NCTSI grantees shall, as
appropriate, collaborate with other such grantees, the NCTSI
coordinating center, and the Secretary in carrying out
subsections (a)(2) and (d)(2).'';</DELETED>
<DELETED> (6) by amending subsection (h) to read as
follows:</DELETED>
<DELETED> ``(h) Application and Evaluation.--To be eligible to
receive a grant, contract, or cooperative agreement under subsection
(a), a public or nonprofit private entity or an Indian Tribe or Tribal
organization shall submit to the Secretary an application at such time,
in such manner, and containing such information and assurances as the
Secretary may require, including--</DELETED>
<DELETED> ``(1) a plan for the rigorous evaluation of the
activities funded under the grant, contract or agreement,
including both process and outcomes evaluation, and the
submission of an evaluation at the end of the project period;
and</DELETED>
<DELETED> ``(2) a description of how such entity, Indian
Tribe, or Tribal organization will support efforts led by the
Secretary or the NCTSI coordinating center, as applicable, to
evaluate activities carried out under this section.'';
and</DELETED>
<DELETED> (7) in subsection (j), by striking ``, $63,887,000
for each of fiscal years 2019 through 2023'' and inserting
``$93,887,000 for each of fiscal years 2024 and 2025,
$104,000,000 for fiscal year 2026, $110,000,000 for fiscal year
2027, and $112,661,000 for fiscal year 2028''.</DELETED>
<DELETED>SEC. 107. SURVEILLANCE AND DATA COLLECTION FOR CHILD, YOUTH,
AND ADULT TRAUMA.</DELETED>
<DELETED> Section 7131(e) of the SUPPORT for Patients and
Communities Act (42 U.S.C. 242t(e)) is amended by striking ``2019
through 2023'' and inserting ``2024 through 2028''.</DELETED>
<DELETED>SEC. 108. PREVENTING ADVERSE CHILDHOOD EXPERIENCES.</DELETED>
<DELETED> (a) Grant Program.--</DELETED>
<DELETED> (1) In general.--The Secretary of Health and Human
Services (referred to in this section as the ``Secretary''),
acting through the Director of the Centers for Disease Control
and Prevention, may award grants or cooperative agreements to
States, territories, Indian Tribes and Tribal organizations (as
such terms are defined in section 4 of the Indian Self-
Determination and Education Assistance Act (25 U.S.C. 5304)),
and local governmental entities for purposes of carrying out
public health activities to improve health outcomes by
preventing or reducing adverse childhood experiences.</DELETED>
<DELETED> (2) Use of funds.--Recipients of an award under
this subsection may use such award to--</DELETED>
<DELETED> (A) identify, implement, and evaluate
evidence-based public health activities to prevent or
reduce adverse childhood experiences and improve health
outcomes;</DELETED>
<DELETED> (B) improve data collection and analysis
regarding the prevention and reduction of adverse
childhood experiences, including any such data
described in section 7131 of the SUPPORT for Patients
and Communities Act (42 U.S.C. 242t), to identify--
</DELETED>
<DELETED> (i) any geographic areas or
populations within the jurisdiction of the
recipient of an award that have
disproportionately high rates of adverse
childhood experiences;</DELETED>
<DELETED> (ii) any types of adverse
childhood experiences of high prevalence within
such jurisdiction; and</DELETED>
<DELETED> (iii) any short-term health
outcomes and long-term health outcomes
associated with adverse childhood experiences,
including mental health and substance use
disorders; and</DELETED>
<DELETED> (C) leverage such data and analysis to
inform the identification, implementation, and
evaluation of evidence-based public health activities
under subparagraph (A).</DELETED>
<DELETED> (3) Partnerships.--Recipients of an award under
this subsection may identify opportunities to establish, or
strengthen existing, partnerships with other relevant public
and private entities within such jurisdiction for purposes of
carrying out such award.</DELETED>
<DELETED> (4) Technical assistance.--The Secretary may
provide training and technical assistance to recipients of
awards under this subsection.</DELETED>
<DELETED> (5) Evaluation.--Not later than 2 years after the
date of enactment of this Act, and annually thereafter, the
Secretary shall report to the Committee on Health, Education,
Labor, and Pensions of the Senate and the Committee on Energy
and Commerce of the House of Representatives on the specific
activities supported through awards under this subsection,
including the effectiveness of such activities in preventing or
reducing adverse childhood experiences.</DELETED>
<DELETED> (b) Research.--The Secretary may, as appropriate, conduct
research to evaluate public health activities to address adverse
childhood experiences.</DELETED>
<DELETED> (c) Authorization of Appropriations.--To carry out this
section, there is authorized to be appropriated $7,000,000 for each of
fiscal years 2024 through 2028.</DELETED>
<DELETED>SEC. 109. CLARIFICATION OF USE OF FUNDS FOR PRODUCTS USED TO
PREVENT OVERDOSE DEATHS.</DELETED>
<DELETED> The activities carried out pursuant to section
1003(b)(4)(A) of the 21st Century Cures Act (42 U.S.C. 290ee-
3a(b)(4)(A)) may include facilitating access to products used to
prevent overdose deaths by detecting the presence of one or more
substances, to the extent the purchase and possession of such products
is consistent with Federal and State law.</DELETED>
<DELETED>SEC. 110. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY
FETAL ALCOHOL SPECTRUM DISORDER.</DELETED>
<DELETED> (a) In General.--Part O of title III of the Public Health
Service Act (42 U.S.C. 280f et seq.) is amended--</DELETED>
<DELETED> (1) by amending the part heading to read as
follows: ``fetal alcohol spectrum disorders prevention and
services program'';</DELETED>
<DELETED> (2) in section 399H (42 U.S.C. 280f)--</DELETED>
<DELETED> (A) in the section heading, by striking
``establishment of fetal alcohol syndrome prevention''
and inserting ``fetal alcohol spectrum disorders
prevention, intervention,'';</DELETED>
<DELETED> (B) by striking ``Fetal Alcohol Syndrome
and Fetal Alcohol Effect'' each place it appears and
inserting ``FASD'';</DELETED>
<DELETED> (C) in subsection (a)--</DELETED>
<DELETED> (i) by amending the heading to
read as follows: ``In General'';</DELETED>
<DELETED> (ii) in the matter preceding
paragraph (1)--</DELETED>
<DELETED> (I) by inserting ``or
continue activities to support'' after
``shall establish'';</DELETED>
<DELETED> (II) by striking ``FASD''
(as amended by subparagraph (B)) and
inserting ``fetal alcohol spectrum
disorders (referred to in this section
as `FASD')'';</DELETED>
<DELETED> (III) by striking
``prevention, intervention'' and
inserting ``awareness, prevention,
identification, intervention,'';
and</DELETED>
<DELETED> (IV) by striking ``that
shall'' and inserting ``, which
may'';</DELETED>
<DELETED> (iii) in paragraph (1)--</DELETED>
<DELETED> (I) in subparagraph (A)--
</DELETED>
<DELETED> (aa) by striking
``medical schools'' and
inserting ``health professions
schools''; and</DELETED>
<DELETED> (bb) by inserting
``infants,'' after ``provision
of services for'';
and</DELETED>
<DELETED> (II) in subparagraph (D),
by striking ``medical and mental'' and
inserting ``agencies
providing'';</DELETED>
<DELETED> (iv) in paragraph (2)--</DELETED>
<DELETED> (I) in the matter
preceding subparagraph (A), by striking
``a prevention and diagnosis program to
support clinical studies,
demonstrations and other research as
appropriate'' and inserting
``supporting and conducting research on
FASD, as appropriate,
including'';</DELETED>
<DELETED> (II) in subparagraph (B)--
</DELETED>
<DELETED> (aa) by striking
``prevention services and
interventions for pregnant,
alcohol-dependent women'' and
inserting ``culturally and
linguistically informed
evidence-based or practice-
based interventions and
appropriate societal supports
for preventing prenatal alcohol
exposure, which may co-occur
with exposure to other
substances''; and</DELETED>
<DELETED> (bb) by striking
``; and'' and inserting a
semicolon;</DELETED>
<DELETED> (v) by striking paragraph (3) and
inserting the following:</DELETED>
<DELETED> ``(3) integrating into surveillance practice an
evidence-based standard case definition for FASD and, in
collaboration with other Federal and outside partners, support
organizations of appropriate medical and mental health
professionals in their development and refinement of evidence-
based clinical diagnostic guidelines and criteria for all FASD;
and</DELETED>
<DELETED> ``(4) building State and Tribal capacity for the
identification, treatment, and support of individuals with FASD
and their families, which may include--</DELETED>
<DELETED> ``(A) utilizing and adapting existing
Federal, State, or Tribal programs to include FASD
identification and FASD-informed support;</DELETED>
<DELETED> ``(B) developing and expanding screening
and diagnostic capacity for FASD;</DELETED>
<DELETED> ``(C) developing, implementing, and
evaluating targeted FASD-informed intervention programs
for FASD;</DELETED>
<DELETED> ``(D) increasing awareness of
FASD;</DELETED>
<DELETED> ``(E) providing training with respect to
FASD for professionals across relevant sectors;
and</DELETED>
<DELETED> ``(F) disseminating information about FASD
and support services to affected individuals and their
families.'';</DELETED>
<DELETED> (D) in subsection (b)--</DELETED>
<DELETED> (i) by striking ``described in
section 399I'';</DELETED>
<DELETED> (ii) by striking ``The Secretary''
and inserting the following:</DELETED>
<DELETED> ``(1) In general.--The Secretary''; and</DELETED>
<DELETED> (iii) by adding at the end the
following:</DELETED>
<DELETED> ``(2) Eligible entities.--To be eligible to
receive a grant, or enter into a cooperative agreement or
contract, under this section, an entity shall--</DELETED>
<DELETED> ``(A) be a State, Indian Tribe or Tribal
organization, local government, scientific or academic
institution, or nonprofit organization; and</DELETED>
<DELETED> ``(B) prepare and submit to the Secretary
an application at such time, in such manner, and
containing such information as the Secretary may
require, including a description of the activities that
the entity intends to carry out using amounts received
under this section.</DELETED>
<DELETED> ``(3) Additional application contents.--The
Secretary may require that an entity using amounts from a
grant, cooperative agreement, or contract under this section
for an activity under subsection (a)(4) include in the
application for such amounts submitted under paragraph (2)(B)--
</DELETED>
<DELETED> ``(A) a designation of an individual to
serve as a FASD State or Tribal coordinator of such
activity; and</DELETED>
<DELETED> ``(B) a description of an advisory
committee the entity will establish to provide guidance
for the entity on developing and implementing a
statewide or Tribal strategic plan to prevent FASD and
provide for the identification, treatment, and support
of individuals with FASD and their families.'';
and</DELETED>
<DELETED> (E) by striking subsections (c) and (d);
and</DELETED>
<DELETED> (F) by adding at the end the
following:</DELETED>
<DELETED> ``(c) Definition of FASD-Informed.--For purposes of this
section, the term `FASD-informed', with respect to support or an
intervention program, means that such support or intervention program
uses culturally and linguistically informed evidence-based or practice-
based interventions and appropriate societal supports to support an
improved quality of life for an individual with FASD and the family of
such individual.''; and</DELETED>
<DELETED> (3) by striking sections 399I, 399J, and 399K (42
U.S.C. 280f-1, 280f-2, 280f-3) and inserting the
following:</DELETED>
<DELETED>``SEC. 399I. FETAL ALCOHOL SPECTRUM DISORDERS CENTERS FOR
EXCELLENCE.</DELETED>
<DELETED> ``(a) In General.--The Secretary shall, as appropriate,
award grants, cooperative agreements, or contracts to public or
nonprofit entities with demonstrated expertise in the prevention of,
identification of, and intervention services with respect to, fetal
alcohol spectrum disorders (referred to in this section as `FASD') and
other related adverse conditions. Such awards shall be for the purposes
of establishing Fetal Alcohol Spectrum Disorders Centers for Excellence
to build local, Tribal, State, and national capacities to prevent the
occurrence of FASD and other related adverse conditions, and to respond
to the needs of individuals with FASD and their families by carrying
out the programs described in subsection (b).</DELETED>
<DELETED> ``(b) Programs.--An entity receiving an award under
subsection (a) may use such award for the following purposes:</DELETED>
<DELETED> ``(1) Initiating or expanding diagnostic capacity
for FASD by increasing screening, assessment, identification,
and diagnosis.</DELETED>
<DELETED> ``(2) Developing and supporting public awareness
and outreach activities, including the use of a range of media
and public outreach, to raise public awareness of the risks
associated with alcohol consumption during pregnancy, with the
goals of reducing the prevalence of FASD and improving the
developmental, health (including mental health), and
educational outcomes of individuals with FASD and supporting
families caring for individuals with FASD.</DELETED>
<DELETED> ``(3) Acting as a clearinghouse for evidence-based
resources on FASD prevention, identification, and culturally
and linguistically informed best practices, including the
maintenance of a national data-based directory on FASD-specific
services in States, Indian Tribes, and local communities, and
disseminating ongoing research and developing resources on FASD
to help inform systems of care for individuals with FASD across
their lifespan.</DELETED>
<DELETED> ``(4) Increasing awareness and understanding of
efficacious, evidence-based screening tools and culturally and
linguistically appropriate evidence-based intervention services
and best practices, which may include by conducting national,
regional, State, Tribal, or peer cross-State webinars,
workshops, or conferences for training community leaders,
medical and mental health and substance use disorder
professionals, education and disability professionals,
families, law enforcement personnel, judges, individuals
working in financial assistance programs, social service
personnel, child welfare professionals, and other service
providers.</DELETED>
<DELETED> ``(5) Improving capacity for State, Tribal, and
local affiliates dedicated to FASD awareness, prevention, and
identification and family and individual support programs and
services.</DELETED>
<DELETED> ``(6) Providing technical assistance to recipients
of grants, cooperative agreements, or contracts under section
399H, as appropriate.</DELETED>
<DELETED> ``(7) Carrying out other functions, as
appropriate.</DELETED>
<DELETED> ``(c) Application.--To be eligible for a grant, contract,
or cooperative agreement under this section, an entity shall submit to
the Secretary an application at such time, in such manner, and
containing such information as the Secretary may require.</DELETED>
<DELETED> ``(d) Subcontracting.--A public or private nonprofit
entity may carry out the following activities required under this
section through contracts or cooperative agreements with other public
and private nonprofit entities with demonstrated expertise in
FASD:</DELETED>
<DELETED> ``(1) Prevention activities.</DELETED>
<DELETED> ``(2) Screening and identification.</DELETED>
<DELETED> ``(3) Resource development and dissemination,
training and technical assistance, administration, and support
of FASD partner networks.</DELETED>
<DELETED> ``(4) Intervention services.</DELETED>
<DELETED>``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.</DELETED>
<DELETED> ``There are authorized to be appropriated to carry out
this part such sums as may be necessary for each of fiscal years 2024
through 2028.''.</DELETED>
<DELETED> (b) Report.--Not later than 4 years after the date of
enactment of this Act, the Secretary of Health and Human Services shall
submit to the Committee on Health, Education, Labor, and Pensions of
the Senate and the Committee on Energy and Commerce of the House of
Representatives a report on the efforts of the Department of Health and
Human Services to advance public awareness on, and facilitate the
identification of best practices related to, fetal alcohol spectrum
disorders identification, prevention, treatment, and support.</DELETED>
<DELETED> (c) Technical Amendment.--Section 519D of the Public
Health Service Act (42 U.S.C. 290bb-25d) is repealed.</DELETED>
<DELETED>SEC. 111. PROMOTING STATE CHOICE IN PDMP SYSTEMS.</DELETED>
<DELETED> Section 399O(h) of the Public Health Service Act (42
U.S.C. 280g-3(h)) is amended by adding the following:</DELETED>
<DELETED> ``(5) Promoting state choice.--Nothing in this
section shall be construed to authorize the Secretary to
require States to use a specific vendor or a specific
interoperability connection other than to align with nationally
recognized, consensus-based open standards, such as in
accordance with sections 3001 and 3004.''.</DELETED>
<DELETED>TITLE II--TREATMENT</DELETED>
<DELETED>SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND
POSTPARTUM WOMEN.</DELETED>
<DELETED> Section 508 of the Public Health Service Act (42 U.S.C.
290bb-1) is amended--</DELETED>
<DELETED> (1) in subsection (d)(11)(C), by striking
``providing health services'' and inserting ``providing health
care services'';</DELETED>
<DELETED> (2) in subsection (g)--</DELETED>
<DELETED> (A) by inserting ``a plan describing''
after ``will provide''; and</DELETED>
<DELETED> (B) by adding at the end the following:
``Such plan may include a description of how such
applicant will target outreach to women
disproportionately impacted by maternal substance use
disorder.''; and</DELETED>
<DELETED> (3) in subsection (s), by striking ``$29,931,000
for each of fiscal years 2019 through 2023'' and inserting
``$38, 931,000 for each of fiscal years 2024 through
2028''.</DELETED>
<DELETED>SEC. 202. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER
TREATMENT WORKFORCE.</DELETED>
<DELETED> Section 781(j) of the Public Health Service Act (42 U.S.C.
295h(j)) is amended by striking ``$25,000,000 for each of fiscal years
2019 through 2023'' and inserting ``$50,000,000 for each of fiscal
years 2024 through 2028''.</DELETED>
<DELETED>SEC. 203. REGIONAL CENTERS OF EXCELLENCE IN SUBSTANCE USE
DISORDER EDUCATION.</DELETED>
<DELETED> Section 551 of the Public Health Service Act (42 U.S.C.
290ee-6) is amended by striking subsection (f).</DELETED>
<DELETED>SEC. 204. MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING
PROGRAM.</DELETED>
<DELETED> Section 756(f) of the Public Health Service Act (42 U.S.C.
294e-1(f)) is amended to read as follows:</DELETED>
<DELETED> ``(f) Authorization of Appropriations.--To carry out this
section, there is authorized to be appropriated the
following:</DELETED>
<DELETED> ``(1) $50,000,000 for fiscal year 2024, to be
allocated as follows:</DELETED>
<DELETED> ``(A) For grants described in subsection
(a)(1), $15,000,000.</DELETED>
<DELETED> ``(B) For grants described in subsection
(a)(2), $15,000,000.</DELETED>
<DELETED> ``(C) For grants described in subsection
(a)(3), $10,000,000.</DELETED>
<DELETED> ``(D) For grants described in subsection
(a)(4), $10,000,000.</DELETED>
<DELETED> ``(2) $55,000,000 for fiscal year 2025, to be
allocated as follows:</DELETED>
<DELETED> ``(A) For grants described in subsection
(a)(1), $16,500,000.</DELETED>
<DELETED> ``(B) For grants described in subsection
(a)(2), $16,500,000.</DELETED>
<DELETED> ``(C) For grants described in subsection
(a)(3), $11,000,000.</DELETED>
<DELETED> ``(D) For grants described in subsection
(a)(4), $11,000,000.</DELETED>
<DELETED> ``(3) $60,000,000 for fiscal year 2026, to be
allocated as follows:</DELETED>
<DELETED> ``(A) For grants described in subsection
(a)(1), $18,000,000.</DELETED>
<DELETED> ``(B) For grants described in subsection
(a)(2), $18,000,000.</DELETED>
<DELETED> ``(C) For grants described in subsection
(a)(3), $12,000,000.</DELETED>
<DELETED> ``(D) For grants described in subsection
(a)(4), $12,000,000.</DELETED>
<DELETED> ``(4) $65,000,000 for fiscal year 2027, to be
allocated as follows:</DELETED>
<DELETED> ``(A) For grants described in subsection
(a)(1), $19,500,000.</DELETED>
<DELETED> ``(B) For grants described in subsection
(a)(2), $19,500,000.</DELETED>
<DELETED> ``(C) For grants described in subsection
(a)(3), $13,000,000.</DELETED>
<DELETED> ``(D) For grants described in subsection
(a)(4), $13,000,000.</DELETED>
<DELETED> ``(5) $75,000,000 for fiscal year 2028, to be
allocated as follows:</DELETED>
<DELETED> ``(A) For grants described in subsection
(a)(1), $22,500,000.</DELETED>
<DELETED> ``(B) For grants described in subsection
(a)(2), $22,500,000.</DELETED>
<DELETED> ``(C) For grants described in subsection
(a)(3), $15,000,000.</DELETED>
<DELETED> ``(D) For grants described in subsection
(a)(4), $15,000,000.''.</DELETED>
<DELETED>SEC. 205. GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER
TREATMENT.</DELETED>
<DELETED> Section 3203 of the SUPPORT for Patients and Communities
Act (21 U.S.C. 823 note) is amended--</DELETED>
<DELETED> (1) by striking subsection (b); and</DELETED>
<DELETED> (2) by striking ``In General--The Secretary'' and
inserting the following:</DELETED>
<DELETED>``The Secretary''.</DELETED>
<DELETED>SEC. 206. GRANTS TO IMPROVE TRAUMA SUPPORT SERVICES AND MENTAL
HEALTH CARE FOR CHILDREN AND YOUTH IN EDUCATIONAL
SETTINGS.</DELETED>
<DELETED> Section 7134 of the SUPPORT for Patients and Communities
Act (42 U.S.C. 280h-7) is amended--</DELETED>
<DELETED> (1) in subsection (a), by striking ``tribal'' and
inserting ``Tribal'';</DELETED>
<DELETED> (2) in subsection (c)--</DELETED>
<DELETED> (A) in paragraph (1), by inserting ``early
intervention,'' after ``screening,'';</DELETED>
<DELETED> (B) in paragraph (3)--</DELETED>
<DELETED> (i) in the matter preceding
subparagraph (A), by inserting ``other staff,''
after ``support personnel,''; and</DELETED>
<DELETED> (ii) in subparagraph (A), by
striking ``social and emotional learning'' and
inserting ``developmentally appropriate
practices''; and</DELETED>
<DELETED> (C) in paragraph (5), by inserting
``reduce stigma associated with mental health care
and'' after ``efforts to'';</DELETED>
<DELETED> (3) in subsection (d)--</DELETED>
<DELETED> (A) in paragraph (4)--</DELETED>
<DELETED> (i) in subparagraph (A), by
striking ``; and'' and inserting a
semicolon;</DELETED>
<DELETED> (ii) in subparagraph (B)--
</DELETED>
<DELETED> (I) by striking ``tribal
organizations as appropriate, other
school personnel'' and inserting
``Tribal organizations as appropriate,
other staff''; and</DELETED>
<DELETED> (II) by striking the
period and inserting ``; and'';
and</DELETED>
<DELETED> (iii) by adding at the end the
following:</DELETED>
<DELETED> ``(C) parents and guardians will be
informed of what trauma support services and mental
health care are available to their students and what
services and care their students receive, in accordance
with the parental consent requirements under subsection
(h)(2).''; and</DELETED>
<DELETED> (B) by adding at the end the
following:</DELETED>
<DELETED> ``(7) A plan for sustaining the program following
the end of the award period.'';</DELETED>
<DELETED> (4) in subsection (f)(1), by inserting ``, which
shall include a description of how the school obtains consent
from the student's parent or guardian for the provision of
trauma support services and mental health care'' after ``this
section'';</DELETED>
<DELETED> (5) in subsection (g), by striking ``tribal'' and
inserting ``Tribal'';</DELETED>
<DELETED> (6) in subsection (h)--</DELETED>
<DELETED> (A) in the subsection heading, by
inserting ``; Application of Certain Provisions'' after
``Construction'';</DELETED>
<DELETED> (B) by striking ``tribal'' each place it
appears and inserting ``Tribal'';</DELETED>
<DELETED> (C) by redesignating paragraphs (1) and
(2) as subparagraphs (A) and (B), respectively, and
adjusting the margins accordingly;</DELETED>
<DELETED> (D) by striking ``Nothing in this
section'' and inserting the following:</DELETED>
<DELETED> ``(1) In general.--Nothing in this section'';
and</DELETED>
<DELETED> (E) by adding at the end the
following:</DELETED>
<DELETED> ``(2) Application of provisions.--</DELETED>
<DELETED> ``(A) Rules.--Section 4001 of the
Elementary and Secondary Education Act of 1965 (not
including the exception under subsection (a)(2)(B)(i)
of such section) shall apply to an entity receiving a
grant, contract, or cooperative agreement under this
section in the same manner as such section 4001 applies
to an entity receiving funding under title IV of such
Act.</DELETED>
<DELETED> ``(B) Privacy protections.--Any education
record of a student collected or maintained under
subsection (c)(4) shall have the protections required
for education records under section 444 of the General
Education Provisions Act.''.</DELETED>
<DELETED> (7) in subsection (k)--</DELETED>
<DELETED> (A) by redesignating paragraphs (5)
through (11) as paragraphs (6) through (12),
respectively; and</DELETED>
<DELETED> (B) by inserting after paragraph (4) the
following:</DELETED>
<DELETED> ``(5) Other staff.--The term `other staff' has the
meaning given such term in section 8101 of the Elementary and
Secondary Education Act of 1965.''; and</DELETED>
<DELETED> (8) in subsection (l), by striking ``2019 through
2023'' and inserting ``2024 through 2028''.</DELETED>
<DELETED>SEC. 207. DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING
PROGRAMS FOR SUBSTANCE USE DISORDER PATIENT
RECORDS.</DELETED>
<DELETED> Section 7053 of the SUPPORT for Patients and Communities
Act (42 U.S.C. 290dd-2 note) is amended by striking subsection
(e).</DELETED>
<DELETED>SEC. 208. TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED
IDENTIFICATION, REFERRAL, AND SUPPORT.</DELETED>
<DELETED> Section 7132 of the SUPPORT for Patients and Communities
Act (Public Law 115-271; 132 Stat. 4046) is amended--</DELETED>
<DELETED> (1) in subsection (b)(1)--</DELETED>
<DELETED> (A) by redesignating subparagraph (CC) as
subparagraph (DD); and</DELETED>
<DELETED> (B) by inserting after subparagraph (BB)
the following:</DELETED>
<DELETED> ``(CC) The Administration for Community
Living.'';</DELETED>
<DELETED> (2) in subsection (d)(1), in the matter preceding
subparagraph (A), by inserting ``, developmental disability
service providers'' before ``, individuals who are'';
and</DELETED>
<DELETED> (3) in subsection (i), by striking ``2023'' and
inserting ``2028''.</DELETED>
<DELETED>SEC. 209. PROGRAM TO SUPPORT COORDINATION AND CONTINUATION OF
CARE FOR DRUG OVERDOSE PATIENTS.</DELETED>
<DELETED> Section 7081 of the SUPPORT for Patients and Communities
Act (42 U.S.C. 290dd-4) is amended by striking subsection
(f).</DELETED>
<DELETED>SEC. 210. REGULATIONS RELATING TO SPECIAL REGISTRATION FOR
TELEMEDICINE.</DELETED>
<DELETED> Not later than 1 year after the date of enactment of this
Act, the Attorney General, in consultation with the Secretary of Health
and Human Services, shall promulgate the final regulations required
under section 311(h)(2) of the Controlled Substances Act (21 U.S.C.
831(h)(2)).</DELETED>
<DELETED>SEC. 211. MENTAL HEALTH PARITY.</DELETED>
<DELETED> (a) In General.--Not later than January 1, 2025, the
Inspector General of the Department of Labor, in coordination with the
Inspector General of the Department of Health and Human Services, shall
report to the Committee on Health, Education, Labor, and Pensions of
the Senate and the Committee on Energy and Commerce and the Committee
on Education and the Workforce of the House of Representatives on the
following:</DELETED>
<DELETED> (1) The non-quantitative treatment limit (referred
to in this section as ``NQTL'') requirements with respect to
mental health and substance use disorder benefits under group
health plans and health insurance issuers under section
2726(a)(8) of the Public Health Service Act (42 U.S.C. 300gg-
26(a)(8)), section 712(a)(8) of the Employee Retirement Income
Security Act of 1974 (29 U.S.C. 1185a(a)(8)), and section
9812(a)(8) of the Internal Revenue Code of 1986 (referred to in
this section as the ``NQTL comparative analysis
requirements''), and the requirements for the Secretary of
Health and Human Services, the Secretary of Labor, and the
Secretary of the Treasury to issue regulations, a compliance
program guide, and additional guidance documents and tools
providing guidance relating to mental health parity
requirements under section 2726(a) of the Public Health Service
Act (42 U.S.C. 300gg-26(a)), section 712(a) of the Employee
Retirement Income Security Act of 1974 (29 U.S.C. 1185a(a)),
and section 9812(a) of the Internal Revenue Code of
1986.</DELETED>
<DELETED> (2) With respect to the NQTL comparative analysis
requirements described in paragraph (1), an analysis of the
actions taken by the Secretary of Labor, the Secretary of the
Treasury, and the Secretary of Health and Human Services to
provide guidance to ensure that group health plans and health
insurance issuers can fully comply with mental health parity
requirements under section 2726 of the Public Health Service
Act (42 U.S.C. 300gg-26), section 712 of the Employee
Retirement Income Security Act of 1974 (29 U.S.C. 1185a), and
section 9812 of the Internal Revenue Code of 1986 and the NQTL
comparative analysis requirements described in paragraph (1),
including an analysis of--</DELETED>
<DELETED> (A) the extent to which the Secretary of
Labor, the Secretary of the Treasury, and the Secretary
of Health and Human Services have fulfilled the
requirement under section 203(b) of division BB of the
Consolidated Appropriations Act, 2021 (Public Law 116-
260) to issue the specific guidance and regulations
pertaining to the requirements for group health plans
and health insurance issuers to demonstrate compliance
with the NQTL comparative analysis requirements;
and</DELETED>
<DELETED> (B) whether sufficient guidance and
examples from the Department of Labor and Department of
Health and Human Services, and the Department of the
Treasury exist to guide and assist group health plans
and health insurance issuers in complying with the
requirements to demonstrate compliance with mental
health parity NQTL comparative analysis requirements/
under such sections 2726(a)(8), 712(a)(8), and
9812(a)(8).</DELETED>
<DELETED> (3) A review of the enforcement processes of the
Department of Labor and the Department of Health and Human
Services to evaluate the consistency of interpretation of the
requirements under section 2726(a)(8) of the Public Health
Service Act (42 U.S.C. 300gg-26(a)(8), section 712(a)(8) of the
Employee Retirement Income Security Act of 1974 (29 U.S.C.
1185a(a)(8)), and section 9812(a)(8) of the Internal Revenue
Code of 1986, in particular with respect to processes utilized
for enforcement, actions or inactions that constitute
noncompliance, and avoidance among the agencies of duplication
of enforcement, including an evaluation of compliance with
section 104 of the Health Insurance Portability and
Accountability Act of 1996 (Public Law 104-191).</DELETED>
<DELETED> (4) A review of the implementation, by the
Department of Labor, Department of Health and Human Services,
and Department of the Treasury, of mental health parity
requirements under section 2726 of the Public Health Service
Act (42 U.S.C. 300gg-26), section 712 of the Employee
Retirement Income Security Act of 1974 (29 U.S.C. 1185a), and
section 9812 of the Internal Revenue Code of 1986, including
all such requirements in effect through the enactment of the
Mental Health Parity Act of 1996 (Public Law 104-204), the Paul
Wellstone and Pete Domenici Mental Health Parity and Addiction
Equity Act of 2008 (Public Law 110-460), the 21st Century Cures
Act (Public Law 114-255), and the Consolidated Appropriations
Act, 2023 (Public Law 117-328) (including any amendments made
by such Acts), and including with respect to the timing of all
actions, delays of any actions, reasons for any such delays,
mandated requirements that were met only once but not each time
such requirements were mandated.</DELETED>
<DELETED> (b) Definitions.--In this section, the terms ``group
health plan'' and ``health insurance issuer'' have the meanings given
such terms in section 733 of the Employee Retirement Income Security
Act of 1974 (29 U.S.C. 1191b).</DELETED>
<DELETED>SEC. 212. STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS
MENTAL ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL
DISTURBANCE.</DELETED>
<DELETED> (a) Review of Use of Certain Funding.--Not later than 1
year after the date of enactment of this Act, the Secretary of Health
and Human Services, acting through the Assistant Secretary for Mental
Health and Substance Use, shall conduct a review of the use by States
of funds made available under the Community Mental Health Services
Block Grant program under subpart I of part B of title XIX of the
Public Health Service Act (42 U.S.C. 300x et seq.) for First Episode
Psychosis activities. Such review shall consider the
following:</DELETED>
<DELETED> (1) How the States use funds for evidence-based
treatments and services, such as coordinated specialty care,
according to the standard of care for individuals with early
serious mental illness, including the comprehensiveness of such
treatments to include all aspects of the recommended
intervention.</DELETED>
<DELETED> (2) How State mental health departments coordinate
with State Medicaid departments in the delivery of the
treatments and services described in paragraph (1).</DELETED>
<DELETED> (3) The percentage of the State funding under the
block grant program that is applied toward early serious mental
illness and funding in excess of, or under, 10 percent of the
amount of the grant, broken down by State.</DELETED>
<DELETED> (4) The percentage of funds expended by States
through such block grant program specifically on First Episode
Psychosis, to the extent such information is
available.</DELETED>
<DELETED> (5) How many individuals are served by the
expenditures described in paragraph (3)and (4), on a per-capita
basis.</DELETED>
<DELETED> (6) How the funds are used to reach underserved
populations, including rural populations and racial and ethnic
minority populations.</DELETED>
<DELETED> (b) Report and Guidance.--</DELETED>
<DELETED> (1) Report.--Not later than 6 months after the
completion of the review under subsection (a), the Secretary of
Health and Human Services, acting through the Assistant
Secretary for Mental Health and Substance Use, shall submit to
the Committee on Appropriations, the Committee on Health,
Education, Labor, and Pensions, and the Committee on Finance of
the Senate and to the Committee on Appropriations and the
Committee on Energy and Commerce of the House of
Representatives a report on the findings made as a result of
the review conducted under subsection (a). Such report shall
include any recommendations with respect to any changes to the
Community Mental Health Services Block Grant program under
subpart I of part B of title XIX of the Public Health Service
Act (42 U.S.C. 300x et seq.), including the set aside required
for First Episode Psychosis, that would facilitate improved
outcomes for the targeted population involved.</DELETED>
<DELETED> (2) Guidance.--Not later than 1 year after the
date on which the report is submitted under paragraph (1), the
Secretary of Health and Human Services, acting through the
Assistant Secretary for Mental Health and Substance Use, shall
update the guidance provided to States under the Community
Mental Health Services Block Grant program based on the
findings and recommendations of the report.</DELETED>
<DELETED> (c) Additional Guidance.--The Director of the National
Institute of Mental Health shall coordinate with the Assistant
Secretary for Mental Health and Substance Use in providing guidance to
State grantees and provider subgrantees about research advances in the
delivery of services for First Episode Psychosis under the Community
Mental Health Services Block Grant program.</DELETED>
<DELETED> (d) Guidance for States Relating to Health Care Services
and Interventions for Individuals With Serious Mental Illness and
Children With Serious Emotional Disturbance.--Not later than 2 years
after the date of enactment of this Act, the Assistant Secretary for
Mental Health and Substance Use, jointly with the Administrator of the
Centers for Medicare & Medicaid Services and the Director of the
National Institute of Mental Health--</DELETED>
<DELETED> (1) shall provide updated guidance to States
concerning the manner in which Federal funding provided to
States through programs administered by such agencies,
including the Community Mental Health Services Block Grant
program under subpart I of part B of title XIX of the Public
Health Service Act (42 U.S.C. 300x et seq.), may be coordinated
to provide evidence-based health care services such as
coordinated specialty care to individuals with serious mental
illness and serious emotional disturbance, and interventions
for individuals with early serious mental illness, including
First Episode Psychosis; and</DELETED>
<DELETED> (2) may streamline relevant State reporting
requirements if such streamlining would result in making it
easier for States to coordinate funding under the programs
described in paragraph (1) to improve treatments for
individuals with serious mental illness and serious emotional
disturbance.</DELETED>
<DELETED>SEC. 213. IMPROVING ACCESS TO ADDICTION MEDICINE
PROVIDERS.</DELETED>
<DELETED> Section 597 of the Public Health Service Act (42 U.S.C.
290ll) is amended--</DELETED>
<DELETED> (1) in subsection (a)(1), by inserting
``diagnosis,'' after ``related to''; and</DELETED>
<DELETED> (2) in subsection (b), by inserting ``addiction
medicine,'' after ``psychiatry,''.</DELETED>
<DELETED>TITLE III--RECOVERY</DELETED>
<DELETED>SEC. 301. YOUTH PREVENTION AND RECOVERY.</DELETED>
<DELETED> Section 7102(c) of the SUPPORT for Patients and
Communities Act (42 U.S.C. 290bb-7a(c)) is amended--</DELETED>
<DELETED> (1) in paragraph (2)--</DELETED>
<DELETED> (A) in subparagraph (A)--</DELETED>
<DELETED> (i) in clause (i)--</DELETED>
<DELETED> (I) by inserting ``, or a
consortia of local educational
agencies,'' after ``a local educational
agency''; and</DELETED>
<DELETED> (II) by striking ``high
schools'' and inserting ``secondary
schools''; and</DELETED>
<DELETED> (ii) in clause (vi), by striking
``tribe, or tribal'' and inserting ``Tribe, or
Tribal'';</DELETED>
<DELETED> (B) by amending subparagraph (E) to read
as follows:</DELETED>
<DELETED> ``(E) Indian tribe; tribal organization.--
The terms `Indian Tribe' and `Tribal organization' have
the meanings given such terms in section 4 of the
Indian Self-Determination and Education Assistance Act
(25 U.S.C. 5304).'';</DELETED>
<DELETED> (C) by redesignating subparagraph (K) as
subparagraph (L); and</DELETED>
<DELETED> (D) by inserting after subparagraph (J)
the following:</DELETED>
<DELETED> ``(K) Secondary school.--The term
`secondary school' has the meaning given such term in
section 8101 of the Elementary and Secondary Education
Act of 1965 (20 U.S.C. 7801).'';</DELETED>
<DELETED> (2) in paragraph (3)(A), in the matter preceding
clause (i)--</DELETED>
<DELETED> (A) by striking ``and abuse'';
and</DELETED>
<DELETED> (B) by inserting ``at increased risk for
substance misuse'' after ``specific
populations'';</DELETED>
<DELETED> (3) in paragraph (4)--</DELETED>
<DELETED> (A) in the matter preceding subparagraph
(A), by striking ``Indian tribes'' and inserting
``Indian Tribes'';</DELETED>
<DELETED> (B) in subparagraph (A), by striking ``and
abuse''; and</DELETED>
<DELETED> (C) in subparagraph (B), by striking
``peer mentoring'' and inserting ``peer-to-peer
support'';</DELETED>
<DELETED> (4) in paragraph (5), by striking ``tribal'' and
inserting ``Tribal'';</DELETED>
<DELETED> (5) in paragraph (6)(A)--</DELETED>
<DELETED> (A) in clause (iv), by striking ``; and''
and inserting a semicolon; and</DELETED>
<DELETED> (B) by adding at the end the
following:</DELETED>
<DELETED> ``(vi) a plan to sustain the
activities carried out under the grant program,
after the grant program has ended;
and'';</DELETED>
<DELETED> (6) in paragraph (8), by striking ``2022'' and
inserting ``2027''; and</DELETED>
<DELETED> (7) by amending paragraph (9) to read as
follows:</DELETED>
<DELETED> ``(9) Authorization of appropriations.--To carry
out this subsection, there are authorized to be appropriated
$10,000,000 for fiscal year 2024, $12,000,000 for fiscal year
2025, $14,000,000 for fiscal year 2026, $16,000,000 for fiscal
year 2027, and $18,000,000 for fiscal year 2028.''.</DELETED>
<DELETED>SEC. 302. COMPREHENSIVE OPIOID RECOVERY CENTERS.</DELETED>
<DELETED> Section 552 of the Public Health Service Act (42 U.S.C.
290ee-7) is amended--</DELETED>
<DELETED> (1) in subsection (d)(2)--</DELETED>
<DELETED> (A) in the matter preceding subparagraph
(A), by striking ``and in such manner'' and inserting
``, in such manner, and containing such information and
assurances''; and</DELETED>
<DELETED> (B) in subparagraph (A), by striking ``is
capable of coordinating with other entities to carry
out'' and inserting ``has the demonstrated capability
to carry out, through referral or contractual
arrangements'';</DELETED>
<DELETED> (2) in subsection (h)--</DELETED>
<DELETED> (A) by redesignating paragraphs (1)
through (4) as subparagraphs (A) through (D),
respectively, and adjusting the margins
accordingly;</DELETED>
<DELETED> (B) by striking ``With respect to'' and
inserting the following:</DELETED>
<DELETED> ``(1) In general.--With respect to'';
and</DELETED>
<DELETED> (C) by adding at the end the
following:</DELETED>
<DELETED> ``(2) Additional reporting for certain eligible
entities.--An entity carrying out activities described in
subsection (g) through referral or contractual arrangements
shall include in the submissions required under paragraph (1)
information related to the status of such referrals or
contractual arrangements, including an assessment of whether
such referrals or contractual arrangements are supporting the
ability of such entity to carry out such activities.'';
and</DELETED>
<DELETED> (3) in subsection (j), by striking ``2019 through
2023'' and inserting ``2024 through 2028''.</DELETED>
<DELETED>SEC. 303. BUILDING COMMUNITIES OF RECOVERY.</DELETED>
<DELETED> Section 547(f) of the Public Health Service Act (42 U.S.C.
290ee-2(f)) is amended by striking ``$5,000,000 for each of fiscal
years 2019 through 2023'' and inserting ``$16,000,000 for each of
fiscal years 2024 through 2028''.</DELETED>
<DELETED>SEC. 304. PEER SUPPORT TECHNICAL ASSISTANCE CENTER.</DELETED>
<DELETED> Section 547A of the Public Health Service Act (42 U.S.C.
290ee-2a) is amended--</DELETED>
<DELETED> (1) in subsection (b)(4), by striking ``building;
and'' and inserting the following: ``building, such as--
</DELETED>
<DELETED> ``(A) professional development of peer
support specialists; and</DELETED>
<DELETED> ``(B) making recovery support services
available in nonclinical settings; and'';</DELETED>
<DELETED> (2) by redesignating subsections (d) and (e) as
subsections (e) and (f), respectively;</DELETED>
<DELETED> (3) by inserting after subsection (c) the
following:</DELETED>
<DELETED> ``(d) Pilot Program.--</DELETED>
<DELETED> ``(1) In general.--The Secretary shall carry out a
pilot program to establish one regional technical assistance
center (referred to in this subsection as the `Regional
Center') to assist the Center in carrying out activities
described in subsection (b) within the geographic region of
such Regional Center in a manner that is tailored to the needs
of such region.</DELETED>
<DELETED> ``(2) Evaluation.--Not later than 4 years after
the date of enactment of the SUPPORT for Patients and
Communities Reauthorization Act, the Secretary shall evaluate
the activities of the Regional Center and submit to the
Committee on Health, Education, Labor, and Pensions of the
Senate and the Committee on Energy and Commerce of the House of
Representatives a report on the findings of such evaluation,
including--</DELETED>
<DELETED> ``(A) a description of the distinct roles
and responsibilities of the Regional Center and the
Center;</DELETED>
<DELETED> ``(B) available information relating to
the outcomes of the pilot program under this
subsection, such as any impact the Regional Center had
on the operations and efficiency of the Center relating
to requests for technical assistance and support within
the region of such Regional Center;</DELETED>
<DELETED> ``(C) a description of any gaps or areas
of duplication relating to the activities of the
Regional Center and the Center within such region;
and</DELETED>
<DELETED> ``(D) recommendations relating to the
modification, expansion, or termination of the pilot
program under this subsection.</DELETED>
<DELETED> ``(3) Termination.--This subsection shall
terminate on September 30, 2028.''; and</DELETED>
<DELETED> (4) in subsection (f), as so redesignated, by
striking ``$1,000,000 for each of fiscal years 2019 through
2023'' and inserting ``$2,000,000 for each of fiscal years 2024
through 2028''.</DELETED>
<DELETED>SEC. 305. CAREER ACT.</DELETED>
<DELETED> (a) In General.--Section 7183 of the SUPPORT for Patients
and Communities Act (42 U.S.C. 290ee-8) is amended--</DELETED>
<DELETED> (1) in the section heading, by inserting ``;
treatment, recovery, and workforce support grants'' after
``career act'';</DELETED>
<DELETED> (2) in subsection (b), by inserting ``each''
before ``for a period'';</DELETED>
<DELETED> (3) in subsection (c)--</DELETED>
<DELETED> (A) in paragraph (1), by striking ``the
rates described in paragraph (2)'' and inserting ``the
average rates for calendar years 2018 through 2022
described in paragraph (2)''; and</DELETED>
<DELETED> (B) by amending paragraph (2) to read as
follows:</DELETED>
<DELETED> ``(2) Rates.--The rates described in this
paragraph are the following:</DELETED>
<DELETED> ``(A) The highest age-adjusted average
rates of drug overdose deaths for calendar years 2018
through 2022 based on data from the Centers for Disease
Control and Prevention, including, if necessary,
provisional data for calendar year 2022.</DELETED>
<DELETED> ``(B) The highest average rates of
unemployment for calendar years 2018 through 2022 based
on data provided by the Bureau of Labor
Statistics.</DELETED>
<DELETED> ``(C) The lowest average labor force
participation rates for calendar years 2018 through
2022 based on data provided by the Bureau of Labor
Statistics.'';</DELETED>
<DELETED> (4) in subsection (g)--</DELETED>
<DELETED> (A) in each of paragraphs (1) and (3), by
redesignating subparagraphs (A) and (B) as clauses (i)
and (ii), respectively, and adjusting the margins
accordingly;</DELETED>
<DELETED> (B) by redesignating paragraphs (1)
through (3) as subparagraphs (A) through (C),
respectively, and adjusting the margins
accordingly;</DELETED>
<DELETED> (C) in the matter preceding subparagraph
(A) (as so redesignated), by striking ``An entity'' and
inserting the following:</DELETED>
<DELETED> ``(1) In general.--An entity''; and</DELETED>
<DELETED> (D) by adding at the end the
following:</DELETED>
<DELETED> ``(2) Transportation services.--An entity
receiving a grant under this section may use not more than 5
percent of the funds for providing transportation for
individuals to participate in an activity supported by a grant
under this section, which transportation shall be to or from a
place of work or a place where the individual is receiving
career and technical education or job training services or
receiving services directly linked to treatment of or recovery
from a substance use disorder.</DELETED>
<DELETED> ``(3) Limitation.--The Secretary may not require
an entity to, or give priority to an entity that plans to, use
the funds of a grant under this section for activities that are
not specified in this subsection.'';</DELETED>
<DELETED> (5) in subsection (i)(2), by inserting ``, which
shall include employment and earnings outcomes described in
subclauses (I) and (III) of section 116(b)(2)(A)(i) of the
Workforce Innovation and Opportunity Act (29 U.S.C.
3141(b)(2)(A)(i)) with respect to the participation of such
individuals with a substance use disorder in programs and
activities funded by the grant under this section'' after
``subsection (g)'';</DELETED>
<DELETED> (6) in subsection (j)--</DELETED>
<DELETED> (A) in paragraph (1), by inserting ``for
grants awarded prior to the date of enactment of the
SUPPORT for Patients and Communities Reauthorization
Act'' after ``grant period under this section'';
and</DELETED>
<DELETED> (B) in paragraph (2)--</DELETED>
<DELETED> (i) in the matter preceding
subparagraph (A), by striking ``2 years after
submitting the preliminary report required
under paragraph (1)'' and inserting ``September
30, 2028''; and</DELETED>
<DELETED> (ii) in subparagraph (A), by
striking ``(g)(3)'' and inserting
``(g)(1)(C)''; and</DELETED>
<DELETED> (7) in subsection (k), by striking ``$5,000,000
for each of fiscal years 2019 through 2023'' and inserting
``$12,000,000 for each of fiscal years 2024 through
2028''.</DELETED>
<DELETED> (b) Clerical Amendment.--The table of contents in section
1(b) of the SUPPORT for Patients and Communities Act (Public Law 115-
271; 132 Stat. 3894) is amended by striking the item relating to
section 7183 and inserting the following:</DELETED>
<DELETED>``Sec. 7183. CAREER Act; treatment, recovery, and workforce
support grants.''.
<DELETED>SEC. 306. OFFICE OF RECOVERY.</DELETED>
<DELETED> Part A of title V of the Public Health Service Act (42
U.S.C. 290aa et seq.) is amended by inserting after section 501C (42
U.S.C. 290aa-0b) the following:</DELETED>
<DELETED>``SEC. 501D. OFFICE OF RECOVERY.</DELETED>
<DELETED> ``(a) In General.--There is established, within the
Substance Abuse and Mental Health Services Administration, an Office of
Recovery (referred to in this section as the `Office').</DELETED>
<DELETED> ``(b) Responsibilities.--The Office shall, taking into
account the perspectives of individuals with demonstrated experience in
mental health or substance use disorder recovery--</DELETED>
<DELETED> ``(1) identify new and emerging challenges related
to the provision of recovery support services;</DELETED>
<DELETED> ``(2) support technical assistance, data analysis,
and evaluation functions in order to assist States, local
governmental entities, Indian Tribes, and Tribal organizations
in implementing and strengthening recovery support services,
consistent with the needs of such States, local governmental
entities, Indian Tribes, and Tribal organizations;
and</DELETED>
<DELETED> ``(3) ensure coordination of efforts to identify,
disseminate, and evaluate best practices related to--</DELETED>
<DELETED> ``(A) improving the capacity of, and
access to, recovery support services; and</DELETED>
<DELETED> ``(B) supporting the training, education,
professional development, and retention of peer support
specialists.</DELETED>
<DELETED> ``(c) Report.--Not later than 4 years after the date of
enactment of the SUPPORT for Patients and Communities Reauthorization
Act, the Assistant Secretary for Mental Health and Substance Use shall
submit to the Committee on Health, Education, Labor, and Pensions of
the Senate and the Committee on Energy and Commerce of the House of
Representatives a report on the activities conducted by the Office,
including--</DELETED>
<DELETED> ``(1) a description of the specific roles and
responsibilities of the Office;</DELETED>
<DELETED> ``(2) a description of the relationship between
the Office and other relevant components or programs of the
Substance Abuse and Mental Health Services
Administration;</DELETED>
<DELETED> ``(3) the identification of any gaps in the
activities of the Substance Abuse and Mental Health Services
Administration or challenges in coordination between the Office
and such relevant components or programs of such agency;
and</DELETED>
<DELETED> ``(4) recommendations related to the continued
operations of the Office.</DELETED>
<DELETED> ``(d) Sunset.--This section shall cease to have force or
effect on September 30, 2028.''.</DELETED>
<DELETED>TITLE IV--TECHNICAL AMENDMENTS</DELETED>
<DELETED>SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO
AN ADMINISTERING PRACTITIONER.</DELETED>
<DELETED> Section 309A(a) of the Controlled Substances Act (21
U.S.C. 829a(a)) is amended by striking paragraph (2) and inserting the
following:</DELETED>
<DELETED> ``(2) the controlled substance is a drug in
schedule III, IV, or V to be administered--</DELETED>
<DELETED> ``(A) by injection or implantation for the
purpose of maintenance or detoxification treatment;
or</DELETED>
<DELETED> ``(B) intranasally, subject to risk
evaluation and mitigation strategy pursuant to section
505-1 of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 355-1), with post-administration monitoring by a
health care professional;''.</DELETED>
<DELETED>SEC. 402. TECHNICAL CORRECTION ON CONTROLLED SUBSTANCES
DISPENSING.</DELETED>
<DELETED> Effective as if included in the enactment of Public Law
117-328--</DELETED>
<DELETED> (1) section 1252(a) of division FF of Public Law
117-328 (136 Stat. 5681) is amended, in the matter being
inserted into section 302(e) of the Controlled Substances Act,
by striking ``303(g)'' and inserting ``303(h)'';</DELETED>
<DELETED> (2) section 1262 of division FF of Public Law 117-
328 (136 Stat. 5681) is amended--</DELETED>
<DELETED> (A) in subsection (a)--</DELETED>
<DELETED> (i) in the matter preceding
paragraph (1), by striking ``303(g)'' and
inserting ``303(h)'';</DELETED>
<DELETED> (ii) in the matter being stricken
by subsection (a)(2), by striking ``(g)(1)''
and inserting ``(h)(1)''; and</DELETED>
<DELETED> (iii) in the matter being inserted
by subsection (a)(2), by striking ``(g)
Practitioners'' and inserting ``(h)
Practitioners''; and</DELETED>
<DELETED> (B) in subsection (b)--</DELETED>
<DELETED> (i) in the matter being stricken
by paragraph (1), by striking ``303(g)(1)'' and
inserting ``303(h)(1)'';</DELETED>
<DELETED> (ii) in the matter being inserted
by paragraph (1), by striking ``303(g)'' and
inserting ``303(h)'';</DELETED>
<DELETED> (iii) in the matter being stricken
by paragraph (2)(A), by striking ``303(g)(2)''
and inserting ``303(h)(2)'';</DELETED>
<DELETED> (iv) in the matter being stricken
by paragraph (3), by striking ``303(g)(2)(B)''
and inserting ``303(h)(2)(B)'';</DELETED>
<DELETED> (v) in the matter being stricken
by paragraph (5), by striking ``303(g)'' and
inserting ``303(h)''; and</DELETED>
<DELETED> (vi) in the matter being stricken
by paragraph (6), by striking ``303(g)'' and
inserting ``303(h)''; and</DELETED>
<DELETED> (3) section 1263(b) of division FF of Public Law
117-328 (136 Stat. 5685) is amended--</DELETED>
<DELETED> (A) by striking ``303(g)(2)'' and
inserting ``303(h)(2)''; and</DELETED>
<DELETED> (B) by striking ``(21 U.S.C. 823(g)(2))''
and inserting ``(21 U.S.C. 823(h)(2))''.</DELETED>
<DELETED>SEC. 403. REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED
SUBSTANCES.</DELETED>
<DELETED> (a) In General.--Section 303 of the Controlled Substances
Act (21 U.S.C. 823) is amended--</DELETED>
<DELETED> (1) by redesignating the second subsection
designated as subsection (l) as subsection (m); and</DELETED>
<DELETED> (2) in subsection (m)(1), as so redesignated--
</DELETED>
<DELETED> (A) in subparagraph (A)--</DELETED>
<DELETED> (i) In clause (iv)--</DELETED>
<DELETED> (I) In subclause (I)--
</DELETED>
<DELETED> (aa) by inserting
``the American Academy of
Family Physicians, the American
Podiatric Medical Association,
the Academy of General
Dentistry,'' before ``or any
other organization'';</DELETED>
<DELETED> (bb) by striking
``or the Commission'' and
inserting ``the Commission'';
and</DELETED>
<DELETED> (cc) by inserting
``, or the Council on Podiatric
Medical Education'' before the
semicolon at the end;
and</DELETED>
<DELETED> (II) in subclause (III),
by inserting ``or the American Academy
of Family Physicians'' after
``Association''; and</DELETED>
<DELETED> (ii) in clause (v), in the matter
preceding subclause (I)--</DELETED>
<DELETED> (I) by striking
``osteopathic medicine, dental
surgery'' and inserting ``osteopathic
medicine, podiatric medicine, dental
surgery''; and</DELETED>
<DELETED> (II) by striking ``or
dental medicine curriculum'' and
inserting ``or dental or podiatric
medicine curriculum''; and</DELETED>
<DELETED> (B) in subparagraph (B)--</DELETED>
<DELETED> (i) in clause (i), by inserting
``the American Pharmacists Association, the
Accreditation Council on Pharmacy Education,
the American Optometric Association, the
American Psychiatric Nurses Association, the
American Academy of Nursing, the American
Academy of Family Physicians'' before ``, or
any other organization''; and</DELETED>
<DELETED> (ii) in clause (ii)--</DELETED>
<DELETED> (I) by striking ``or
accredited school'' and inserting ``,
an accredited school''; and</DELETED>
<DELETED> (II) by inserting ``, or
an accredited school of pharmacy''
before ``in the United
States''.</DELETED>
<DELETED> (b) Effective Date.--The amendment made by subsection (a)
shall take effect as if enacted on December 29, 2022.</DELETED>
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
(a) Short Title.--This Act may be cited as the ``SUPPORT for
Patients and Communities Reauthorization Act''.
(b) Table of Contents.--The table of contents for this Act is as
follows:
Sec. 1. Short title; table of contents.
TITLE I--PREVENTION
Sec. 101. First responder training program.
Sec. 102. Surveillance and education regarding infections associated
with illicit drug use and other risk
factors.
Sec. 103. Preventing overdoses of controlled substances.
Sec. 104. Pilot program for public health laboratories to detect
fentanyl and other synthetic opioids.
Sec. 105. Prenatal and postnatal health.
Sec. 106. Donald J. Cohen National Child Traumatic Stress Initiative.
Sec. 107. Surveillance and data collection for child, youth, and adult
trauma.
Sec. 108. Preventing adverse childhood experiences.
Sec. 109. Clarification of use of funds for products used to prevent
overdose deaths.
Sec. 110. Support for individuals and families impacted by fetal
alcohol spectrum disorder.
Sec. 111. Promoting State choice in PDMP systems.
Sec. 112. Protecting Suicide Prevention Lifeline from cybersecurity
incidents.
Sec. 113. Bruce's Law.
Sec. 114. Guidance on at-home drug disposal systems.
Sec. 115. Review of opioid drugs and actions.
Sec. 116. Consideration of enriched enrollment randomized withdrawal
methodology.
Sec. 117. Approval of new opioid analgesic drugs.
Sec. 118. Guidance on developing non-addictive medical products to
treat pain or addiction.
Sec. 119. National Chronic Pain Information System.
Sec. 120. Requirements for electronic-prescribing for controlled
substances under group health plans and
group and individual health insurance
coverage.
TITLE II--TREATMENT
Sec. 201. Residential treatment program for pregnant and postpartum
women.
Sec. 202. Loan repayment program for substance use disorder treatment
workforce.
Sec. 203. Regional centers of excellence in substance use disorder
education.
Sec. 204. Mental and behavioral health education and training program.
Sec. 205. Grants to enhance access to substance use disorder treatment.
Sec. 206. Grants to improve trauma support services and mental health
care for children and youth in educational
settings.
Sec. 207. Development and dissemination of model training programs for
substance use disorder patient records.
Sec. 208. Task force on best practices for trauma-informed
identification, referral, and support.
Sec. 209. Program to support coordination and continuation of care for
drug overdose patients.
Sec. 210. Regulations relating to special registration for
telemedicine.
Sec. 211. Mental health parity.
Sec. 212. State guidance related to individuals with serious mental
illness and children with serious emotional
disturbance.
Sec. 213. Improving access to addiction medicine providers.
Sec. 214. Roundtable on using health information technology to improve
mental health and substance use care
outcomes.
Sec. 215. Peer-to-peer mental health support.
Sec. 216. Kid PROOF pilot program.
TITLE III--RECOVERY
Sec. 301. Youth prevention and recovery.
Sec. 302. Comprehensive opioid recovery centers.
Sec. 303. Building communities of recovery.
Sec. 304. Peer support technical assistance center.
Sec. 305. CAREER Act.
Sec. 306. Research and recommendations on criminal background check
process for peer support specialists.
Sec. 307. Office of Recovery.
Sec. 308. Review of Grants.gov.
TITLE IV--TECHNICAL AMENDMENTS
Sec. 401. Delivery of a controlled substance by a pharmacy to an
administering practitioner.
Sec. 402. Technical correction on controlled substances dispensing.
Sec. 403. Required training for prescribers of controlled substances.
TITLE I--PREVENTION
SEC. 101. FIRST RESPONDER TRAINING PROGRAM.
Section 546 of the Public Health Service Act (42 U.S.C. 290ee-1) is
amended--
(1) in subsection (a), by striking ``tribes and tribal''
and inserting ``Tribes and Tribal'';
(2) in subsections (a), (c), and (d)--
(A) by striking ``approved or cleared'' each place
it appears and inserting ``approved, cleared, or
otherwise legally marketed''; and
(B) by striking ``opioid'' each place it appears;
(3) in subsection (f)--
(A) by striking ``approved or cleared'' each place
it appears and inserting ``approved, cleared, or
otherwise legally marketed'';
(B) in paragraph (1), by striking ``opioid'';
(C) in paragraph (2)--
(i) by striking ``opioid and heroin'' and
inserting ``opioid, heroin, and other drug'';
and
(ii) by striking ``opioid overdose'' and
inserting ``overdose''; and
(D) in paragraph (3), by striking ``opioid and
heroin''; and
(4) in subsection (h), by striking ``$36,000,000 for each
of fiscal years 2019 through 2023'' and inserting ``$56,000,000
for each of fiscal years 2024 through 2028''.
SEC. 102. SURVEILLANCE AND EDUCATION REGARDING INFECTIONS ASSOCIATED
WITH ILLICIT DRUG USE AND OTHER RISK FACTORS.
Section 317N(d) of the Public Health Service Act (42 U.S.C. 247b-
15(d)) is amended by striking ``2019 through 2023'' and inserting
``2024 through 2028''.
SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES.
Section 392A of the Public Health Service Act (42 U.S.C. 280b-1) is
amended--
(1) in subsection (a)--
(A) in paragraph (2)--
(i) in subparagraph (C), by inserting ``and
associated risks'' before the period at the
end; and
(ii) in subparagraph (D), by striking
``opioids'' and inserting ``substances causing
overdose'';
(B) in paragraph (3)(A)--
(i) by inserting ``identify substances
causing overdose and'' after ``rapidly''; and
(ii) by striking ``abuse, and overdoses''
and inserting ``overdoses, and associated risk
factors'';
(2) in subsection (b)(2)--
(A) in subparagraph (B), by inserting ``, and
associated risk factors,'' after ``such overdoses'';
(B) in subparagraph (C), by striking ``coding'' and
inserting ``monitoring and identifying'';
(C) in subparagraph (E)--
(i) by inserting a comma after ``public
health laboratories''; and
(ii) by inserting ``and other emerging
substances related'' after ``analogues''; and
(D) in subparagraph (F,) by inserting ``and
associated risk factors'' after ``overdoses''; and
(3) in subsection (e), by striking ``$496,000,000 for each
of fiscal years 2019 through 2023'' and inserting
``$505,579,000 for each of fiscal years 2024 through 2028''.
SEC. 104. PILOT PROGRAM FOR PUBLIC HEALTH LABORATORIES TO DETECT
FENTANYL AND OTHER SYNTHETIC OPIOIDS.
Section 7011 of the SUPPORT for Patients and Communities Act (42
U.S.C. 247d-10) is amended by striking subsection (d).
SEC. 105. PRENATAL AND POSTNATAL HEALTH.
Section 317L(d) of the Public Health Service Act (42 U.S.C. 247b-
13(d)) is amended by striking ``2019 through 2023'' and inserting
``2024 through 2028''.
SEC. 106. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS INITIATIVE.
Section 582 of the Public Health Service Act (42 U.S.C. 290hh-1) is
amended--
(1) in the section heading, by striking ``violence related
stress'' and inserting ``traumatic events'';
(2) in subsection (a)--
(A) in the matter preceding paragraph (1), by
striking ``tribes and tribal'' and inserting ``Tribes
and Tribal''; and
(B) in paragraph (2), by inserting ``and
dissemination'' after ``the development'';
(3) in subsection (b), by inserting ``and dissemination''
after ``the development'';
(4) in subsection (d)--
(A) by striking ``The NCTSI'' and inserting the
following:
``(1) Coordinating center.--The NCTSI''; and
(B) by adding at the end the following:
``(2) NCTSI grantees.--In carrying out subsection (a)(2),
NCTSI grantees shall develop trainings and other resources, as
applicable and appropriate, to support implementation of the
evidence-based practices developed and disseminated under such
subsection.'';
(5) in subsection (e)--
(A) by redesignating paragraphs (1) and (2) as
subparagraphs (A) and (B), respectively, and adjusting
the margins accordingly;
(B) in subparagraph (A), as so redesignated, by
inserting ``and implementation'' after ``the
dissemination'';
(C) by striking ``The NCTSI'' and inserting the
following:
``(1) Coordinating center.--''; and
(D) by adding at the end the following:
``(2) NCTSI grantees.--NCTSI grantees shall, as
appropriate, collaborate with other such grantees, the NCTSI
coordinating center, and the Secretary in carrying out
subsections (a)(2) and (d)(2).'';
(6) by amending subsection (h) to read as follows:
``(h) Application and Evaluation.--To be eligible to receive a
grant, contract, or cooperative agreement under subsection (a), a
public or nonprofit private entity or an Indian Tribe or Tribal
organization shall submit to the Secretary an application at such time,
in such manner, and containing such information and assurances as the
Secretary may require, including--
``(1) a plan for the rigorous evaluation of the activities
funded under the grant, contract, or agreement, including both
process and outcomes evaluation, and the submission of an
evaluation at the end of the project period; and
``(2) a description of how such entity, Indian Tribe, or
Tribal organization will support efforts led by the Secretary
or the NCTSI coordinating center, as applicable, to evaluate
activities carried out under this section.''; and
(7) in subsection (j), by striking ``, $63,887,000 for each
of fiscal years 2019 through 2023'' and inserting ``$93,887,000
for each of fiscal years 2024 and 2025, $104,000,000 for fiscal
year 2026, $110,000,000 for fiscal year 2027, and $112,661,000
for fiscal year 2028''.
SEC. 107. SURVEILLANCE AND DATA COLLECTION FOR CHILD, YOUTH, AND ADULT
TRAUMA.
Section 7131(e) of the SUPPORT for Patients and Communities Act (42
U.S.C. 242t(e)) is amended by striking ``2019 through 2023'' and
inserting ``2024 through 2028''.
SEC. 108. PREVENTING ADVERSE CHILDHOOD EXPERIENCES.
(a) Grant Program.--
(1) In general.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary''), acting
through the Director of the Centers for Disease Control and
Prevention, may award grants or cooperative agreements to
States, territories, Indian Tribes and Tribal organizations (as
such terms are defined in section 4 of the Indian Self-
Determination and Education Assistance Act (25 U.S.C. 5304)),
and local governmental entities for purposes of carrying out
public health activities to improve health outcomes by
preventing or reducing adverse childhood experiences.
(2) Use of funds.--Recipients of an award under this
subsection may use such award to--
(A) identify, implement, and evaluate evidence-
based public health activities to prevent or reduce
adverse childhood experiences and improve health
outcomes;
(B) improve data collection and analysis regarding
the prevention and reduction of adverse childhood
experiences, including any such data described in
section 7131 of the SUPPORT for Patients and
Communities Act (42 U.S.C. 242t), to identify--
(i) any geographic areas or populations
within the jurisdiction of the recipient of an
award that have disproportionately high rates
of adverse childhood experiences;
(ii) any types of adverse childhood
experiences of high prevalence within such
jurisdiction; and
(iii) any short-term health outcomes and
long-term health outcomes associated with
adverse childhood experiences, including mental
health and substance use disorders; and
(C) leverage such data and analysis to inform the
identification, implementation, and evaluation of
evidence-based public health activities under
subparagraph (A).
(3) Partnerships.--Recipients of an award under this
subsection may identify opportunities to establish, or
strengthen existing, partnerships with other relevant public
and private entities within such jurisdiction for purposes of
carrying out such award.
(4) Technical assistance.--The Secretary may provide
training and technical assistance to recipients of awards under
this subsection.
(5) Evaluation.--Not later than 2 years after the date of
enactment of this Act, and annually thereafter, the Secretary
shall report to the Committee on Health, Education, Labor, and
Pensions of the Senate and the Committee on Energy and Commerce
of the House of Representatives on the specific activities
supported through awards under this subsection, including the
effectiveness of such activities in preventing or reducing
adverse childhood experiences.
(b) Research.--The Secretary may, as appropriate, conduct research
to evaluate public health activities to address adverse childhood
experiences.
(c) Authorization of Appropriations.--To carry out this section,
there is authorized to be appropriated $7,000,000 for each of fiscal
years 2024 through 2028.
SEC. 109. CLARIFICATION OF USE OF FUNDS FOR PRODUCTS USED TO PREVENT
OVERDOSE DEATHS.
The activities carried out pursuant to section 1003(b)(4)(A) of the
21st Century Cures Act (42 U.S.C. 290ee-3a(b)(4)(A)) may include
facilitating access to products used to prevent overdose deaths by
detecting the presence of one or more substances, to the extent the
purchase and possession of such products is consistent with Federal and
State law.
SEC. 110. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY FETAL
ALCOHOL SPECTRUM DISORDER.
(a) In General.--Part O of title III of the Public Health Service
Act (42 U.S.C. 280f et seq.) is amended--
(1) by amending the part heading to read as follows:
``fetal alcohol spectrum disorders prevention and services
program'';
(2) in section 399H (42 U.S.C. 280f)--
(A) in the section heading, by striking
``establishment of fetal alcohol syndrome prevention''
and inserting ``fetal alcohol spectrum disorders
prevention, intervention,'';
(B) by striking ``Fetal Alcohol Syndrome and Fetal
Alcohol Effect'' each place it appears and inserting
``FASD'';
(C) in subsection (a)--
(i) by amending the heading to read as
follows: ``In General'';
(ii) in the matter preceding paragraph
(1)--
(I) by inserting ``or continue
activities to support'' after ``shall
establish'';
(II) by striking ``FASD'' (as
amended by subparagraph (B)) and
inserting ``fetal alcohol spectrum
disorders (referred to in this section
as `FASD')'';
(III) by striking ``prevention,
intervention'' and inserting
``awareness, prevention,
identification, intervention,''; and
(IV) by striking ``that shall'' and
inserting ``, which may'';
(iii) in paragraph (1)--
(I) in subparagraph (A)--
(aa) by striking ``medical
schools'' and inserting
``health professions schools'';
and
(bb) by inserting
``infants,'' after ``provision
of services for''; and
(II) in subparagraph (D), by
striking ``medical and mental'' and
inserting ``agencies providing'';
(iv) in paragraph (2)--
(I) in the matter preceding
subparagraph (A), by striking ``a
prevention and diagnosis program to
support clinical studies,
demonstrations and other research as
appropriate'' and inserting
``supporting and conducting research on
FASD, as appropriate, including'';
(II) in subparagraph (B)--
(aa) by striking
``prevention services and
interventions for pregnant,
alcohol-dependent women'' and
inserting ``culturally and
linguistically appropriate
evidence-based or evidence-
informed interventions and
appropriate societal supports
for preventing prenatal alcohol
exposure, which may co-occur
with exposure to other
substances''; and
(bb) by striking ``; and''
and inserting a semicolon;
(v) by striking paragraph (3) and inserting
the following:
``(3) integrating into surveillance a case definition for
FASD and, in collaboration with other Federal and outside
partners, support organizations of appropriate medical and
mental health professionals in their development and refinement
of evidence-based clinical diagnostic guidelines and criteria
for all FASD; and
``(4) building State and Tribal capacity for the
identification, treatment, and support of individuals with FASD
and their families, which may include--
``(A) utilizing and adapting existing Federal,
State, or Tribal programs to include FASD
identification and FASD-informed support;
``(B) developing and expanding screening and
diagnostic capacity for FASD;
``(C) developing, implementing, and evaluating
targeted FASD-informed intervention programs for FASD;
``(D) increasing awareness of FASD;
``(E) providing training with respect to FASD for
professionals across relevant sectors; and
``(F) disseminating information about FASD and
support services to affected individuals and their
families.'';
(D) in subsection (b)--
(i) by striking ``described in section
399I'';
(ii) by striking ``The Secretary'' and
inserting the following:
``(1) In general.--The Secretary''; and
(iii) by adding at the end the following:
``(2) Eligible entities.--To be eligible to receive a
grant, or enter into a cooperative agreement or contract, under
this section, an entity shall--
``(A) be a State, Indian Tribe or Tribal
organization, local government, scientific or academic
institution, or nonprofit organization; and
``(B) prepare and submit to the Secretary an
application at such time, in such manner, and
containing such information as the Secretary may
require, including a description of the activities that
the entity intends to carry out using amounts received
under this section.
``(3) Additional application contents.--The Secretary may
require that an eligible entity include in the application
submitted under paragraph (2)(B)--
``(A) a designation of an individual to serve as a
FASD State or Tribal coordinator of activities such
eligible entity proposes to carry out through a grant,
cooperative agreement, or contract under this section;
and
``(B) a description of an advisory committee the
entity will establish to provide guidance for the
entity on developing and implementing a statewide or
Tribal strategic plan to prevent FASD and provide for
the identification, treatment, and support of
individuals with FASD and their families.''; and
(E) by striking subsections (c) and (d); and
(F) by adding at the end the following:
``(c) Definition of FASD-informed.--For purposes of this section,
the term `FASD-informed', with respect to support or an intervention
program, means that such support or intervention program uses
culturally and linguistically informed evidence-based or practice-based
interventions and appropriate societal supports to support an improved
quality of life for an individual with FASD and the family of such
individual.''; and
(3) by striking sections 399I, 399J, and 399K (42 U.S.C.
280f-1, 280f-2, 280f-3) and inserting the following:
``SEC. 399I. FETAL ALCOHOL SPECTRUM DISORDERS CENTERS FOR EXCELLENCE.
``(a) In General.--The Secretary shall, as appropriate, award
grants, cooperative agreements, or contracts to public or nonprofit
private entities with demonstrated expertise in the prevention of,
identification of, and intervention services with respect to, fetal
alcohol spectrum disorders (referred to in this section as `FASD') and
other related adverse conditions. Such awards shall be for the purposes
of establishing Fetal Alcohol Spectrum Disorders Centers for Excellence
to build local, Tribal, State, and nationwide capacities to prevent the
occurrence of FASD and other related adverse conditions, and to respond
to the needs of individuals with FASD and their families by carrying
out the programs described in subsection (b).
``(b) Programs.--An entity receiving an award under subsection (a)
may use such award for the following purposes:
``(1) Initiating or expanding diagnostic capacity for FASD
by increasing screening, assessment, identification, and
diagnosis.
``(2) Developing and supporting public awareness and
outreach activities, including the use of a range of media and
public outreach, to raise public awareness of the risks
associated with alcohol consumption during pregnancy, with the
goals of reducing the prevalence of FASD and improving the
developmental, health (including mental health), and
educational outcomes of individuals with FASD and supporting
families caring for individuals with FASD.
``(3) Acting as a clearinghouse for evidence-based
resources on FASD prevention, identification, and culturally
and linguistically appropriate best practices, including the
maintenance of a national data-based directory on FASD-specific
services in States, Indian Tribes, and local communities, and
disseminating ongoing research and developing resources on FASD
to help inform systems of care for individuals with FASD across
their lifespan.
``(4) Increasing awareness and understanding of
efficacious, evidence-based screening tools and culturally and
linguistically appropriate evidence-based intervention services
and best practices, which may include by conducting nationwide,
regional, State, Tribal, or peer cross-State webinars,
workshops, or conferences for training community leaders,
medical and mental health and substance use disorder
professionals, education and disability professionals,
families, law enforcement personnel, judges, individuals
working in financial assistance programs, social service
personnel, child welfare professionals, and other service
providers.
``(5) Improving capacity for State, Tribal, and local
affiliates dedicated to FASD awareness, prevention, and
identification and family and individual support programs and
services.
``(6) Providing technical assistance to recipients of
grants, cooperative agreements, or contracts under section
399H, as appropriate.
``(7) Carrying out other functions, as appropriate.
``(c) Application.--To be eligible for a grant, contract, or
cooperative agreement under this section, an entity shall submit to the
Secretary an application at such time, in such manner, and containing
such information as the Secretary may require.
``(d) Subcontracting.--A public or private nonprofit entity may
carry out the following activities required under this section through
contracts or cooperative agreements with other public and private
nonprofit entities with demonstrated expertise in FASD:
``(1) Prevention activities.
``(2) Screening and identification.
``(3) Resource development and dissemination, training and
technical assistance, administration, and support of FASD
partner networks.
``(4) Intervention and treatment services.
``SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.
``There are authorized to be appropriated to carry out this part
such sums as may be necessary for each of fiscal years 2024 through
2028.''.
(b) Report.--Not later than 4 years after the date of enactment of
this Act, the Secretary of Health and Human Services shall submit to
the Committee on Health, Education, Labor, and Pensions of the Senate
and the Committee on Energy and Commerce of the House of
Representatives a report on the efforts of the Department of Health and
Human Services to advance public awareness of, and facilitate the
identification of best practices related to, fetal alcohol spectrum
disorders identification, prevention, treatment, and support.
(c) Technical Amendment.--Section 519D of the Public Health Service
Act (42 U.S.C. 290bb-25d) is repealed.
SEC. 111. PROMOTING STATE CHOICE IN PDMP SYSTEMS.
Section 399O(h) of the Public Health Service Act (42 U.S.C. 280g-
3(h)) is amended by adding the following:
``(5) Promoting state choice.--Nothing in this section
shall be construed to authorize the Secretary to require States
to use a specific vendor or a specific interoperability
connection other than to align with nationally recognized,
consensus-based open standards, such as in accordance with the
application programming interface (API) requirements pursuant
to sections 3001 and 3004.''.
SEC. 112. PROTECTING SUICIDE PREVENTION LIFELINE FROM CYBERSECURITY
INCIDENTS.
(a) National Suicide Prevention Lifeline Program.--Section 520E-
3(b) of the Public Health Service Act (42 U.S.C. 290bb-36c(b)) is
amended--
(1) in paragraph (4), by striking ``and'' at the end;
(2) in paragraph (5), by striking the period at the end and
inserting ``; and''; and
(3) by adding at the end the following:
``(6) taking such steps as may be necessary to ensure the
suicide prevention hotline is protected from cybersecurity
incidents and eliminates known cybersecurity
vulnerabilities.''.
(b) Reporting.--Section 520E-3 of the Public Health Service Act (42
U.S.C. 290bb-36c) is amended--
(1) by redesignating subsection (f) as subsection (g); and
(2) by inserting after subsection (e) the following:
``(f) Cybersecurity Reporting.--
``(1) Notification.--
``(A) In general.--The program's network
administrator receiving Federal funding pursuant to
subsection (a) shall report to the Assistant Secretary,
in a manner that protects personal privacy, consistent
with applicable Federal and State privacy laws--
``(i) any identified cybersecurity
vulnerabilities to the program within a
reasonable amount of time after identification
of such a vulnerability; and
``(ii) any identified cybersecurity
incidents to the program within a reasonable
amount of time after identification of such
incident.
``(B) Local and regional crisis centers.--Local and
regional crisis centers participating in the program
shall report to the program's network administrator
identified under subparagraph (A), in a manner that
protects personal privacy, consistent with applicable
Federal and State privacy laws--
``(i) any identified cybersecurity
vulnerabilities to the program within a
reasonable amount of time after identification
of such vulnerability; and
``(ii) any identified cybersecurity
incidents to the program within a reasonable
amount of time after identification of such
incident.
``(2) Notification.--If the program's network administrator
receiving funding pursuant to subsection (a) discovers, or is
informed by a local or regional crisis center pursuant to
paragraph (1)(B) of, a cybersecurity vulnerability or incident,
within a reasonable amount of time after such discovery or
receipt of information, such entity shall report the
vulnerability or incident to the Assistant Secretary.
``(3) Clarification.--
``(A) Oversight.--
``(i) Local and regional crisis centers.--
Except as provided in clause (ii), local and
regional crisis centers participating in the
program shall oversee all technology each
center employs in the provision of services as
a participant in the program.
``(ii) Network administrator.--The
program's network administrator receiving
Federal funding pursuant to subsection (a)
shall oversee the technology each crisis center
employs in the provision of services as a
participant in the program if such oversight
responsibilities are established in the
applicable network participation agreement.
``(B) Supplement, not supplant.--The cybersecurity
incident reporting requirements under this subsection
shall supplement, and not supplant, cybersecurity
incident reporting requirements under other provisions
of applicable Federal law that are in effect on the
date of the enactment of the SUPPORT for Patients and
Communities Reauthorization Act.''.
(c) Study.--Not later than 180 days after the date of the enactment
of this Act, the Comptroller General of the United States shall--
(1) conduct and complete a study that evaluates
cybersecurity risks and vulnerabilities associated with the 9-
8-8 National Suicide Prevention Lifeline; and
(2) submit a report of the findings of such study to the
Committee on Health, Education, Labor, and Pensions of the
Senate and the Committee on Energy and Commerce of the House of
Representatives.
SEC. 113. BRUCE'S LAW.
(a) Youth Prevention and Recovery.--Section 7102(c) of the SUPPORT
for Patients and Communities Act (42 U.S.C. 290bb-7a(c)) is amended--
(1) in paragraph (3)(A)(i), by inserting ``, which may
include strategies to increase education and awareness of the
potency and dangers of synthetic opioids (including drugs
contaminated with fentanyl) and, as appropriate, other emerging
drug use or misuse issues'' before the semicolon; and
(2) in paragraph (4)(A), by inserting ``and strategies to
increase education and awareness of the potency and dangers of
synthetic opioids (including drugs contaminated with fentanyl)
and, as appropriate, emerging drug use or misuse issues''
before the semicolon.
(b) Interdepartmental Substance Use Disorders Coordinating
Committee.--Section 7022 of the SUPPORT for Patients and Communities
Act (42 U.S.C. 290aa note) is amended--
(1) by striking subsection (g) and inserting the following:
``(g) Working Groups.--
``(1) In general.--The Committee may establish working
groups for purposes of carrying out the duties described in
subsection (e). Any such working group shall be composed of
members of the Committee (or the designees of such members) and
may hold such meetings as are necessary to enable the working
group to carry out the duties delegated to the working group.
``(2) Additional federal interagency work group on fentanyl
contamination of illegal drugs.--
``(A) Establishment.--The Secretary, acting through
the Committee, shall establish a Federal Interagency
Work Group on Fentanyl Contamination of Illegal Drugs
(referred to in this paragraph as the `Work Group'),
consisting of representatives from relevant Federal
departments and agencies on the Committee.
``(B) Consultation.--The Work Group shall consult
with relevant stakeholders and subject matter experts,
including--
``(i) State, Tribal, and local subject
matter experts in reducing, preventing, and
responding to drug overdose caused by fentanyl
contamination of illicit drugs; and
``(ii) family members of both adults and
youth who have overdosed by fentanyl-
contaminated illicit drugs.
``(C) Duties.--The Work Group shall--
``(i) examine Federal efforts to reduce and
prevent drug overdose by fentanyl-contaminated
illicit drugs;
``(ii) identify strategies to improve
State, Tribal, and local responses to overdose
by fentanyl-contaminated illicit drugs;
``(iii) coordinate with the Secretary, as
appropriate, in carrying out activities to
raise public awareness of synthetic opioids and
other emerging drug use and misuse issues;
``(iv) make recommendations to Congress for
improving Federal programs, including with
respect to the coordination of efforts across
such programs; and
``(v) make recommendations for educating
youth on the potency and dangers of drugs
contaminated by fentanyl.
``(D) Annual report to secretary.--The Work Group
shall annually prepare and submit to the Secretary, the
Committee on Health, Education, Labor, and Pensions of
the Senate, and the Committee on Education and the
Workforce of the House of Representatives, a report on
the activities carried out by the Work Group under
subparagraph (C), including recommendations to reduce
and prevent drug overdose by fentanyl contamination of
illegal drugs, in all populations, and specifically
among youth at risk for substance misuse.''; and
(2) by striking subsection (i) and inserting the following:
``(i) Sunset.--The Committee shall terminate on September 30,
2028.''.
SEC. 114. GUIDANCE ON AT-HOME DRUG DISPOSAL SYSTEMS.
(a) In General.--Not later than one year after the date of
enactment of this Act, the Secretary of Health and Human Services
(referred to in this section as the ``Secretary''), in consultation
with the Administrator of the Drug Enforcement Administration, shall
publish guidance to facilitate the use of at-home safe disposal systems
for applicable drugs, including for such at-home safe disposal systems
that the Secretary may require as a part of a risk evaluation and
mitigation strategy under section 505-1 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 355-1).
(b) Contents.--The guidance under subsection (a) shall include--
(1) recommended standards for effective at-home drug
disposal systems to meet applicable statutory or regulatory
requirements enforced by the Food and Drug Administration and,
as appropriate, the Drug Enforcement Administration;
(2) recommended information to include as instructions for
use to disseminate with at-home drug disposal systems;
(3) best practices and educational tools to support the use
of an at-home drug disposal system; and
(4) recommended use of licensed health providers for the
dissemination of education, instruction, and at-home drug
disposal systems.
SEC. 115. REVIEW OF OPIOID DRUGS AND ACTIONS.
Not later than one year after the date of enactment of this Act,
the Secretary of Health and Human Services (referred to in this section
as the ``Secretary'') shall publish on the website of the Food and Drug
Administration (referred to in this section as the ``FDA'') a report
that outlines a plan for completing a review of opioid analgesic drugs
that are approved under section 505 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 355) that considers the public health effects
of such opioid drugs as part of the benefit-risk assessment, and that
addresses the activities of the FDA that relate to increasing the
development of non-addictive medical products intended to treat pain or
addiction. Such report shall include--
(1) an opportunity for public input concerning the
regulation by the FDA of opioid analgesic drugs, including
scientific evidence that relates to conditions of use, safety,
or benefit-risk assessment (including consideration of the
public health effects) of such opioid drugs;
(2) an update on the actions taken by the FDA to review the
effectiveness, safety, benefit-risk profile (which may include
public health effects), and use of approved opioid analgesic
drugs;
(3) a timeline for an assessment of the potential need, as
appropriate, for labeling changes, revised or additional
postmarketing requirements, enforcement actions, or withdrawals
for opioid analgesic drugs;
(4) an overview of the steps that the FDA has taken to
support the development and approval of non-addictive medical
products intended to treat pain or addiction, and actions
planned to further support the development and approval of such
products; and
(5) an overview of the consideration by the FDA of clinical
trial methodologies for analgesic drugs, including the enriched
enrollment randomized withdrawal methodology, and the benefits
and drawbacks associated with different trial methodologies for
such drugs, incorporating any public input received under
paragraph (1).
SEC. 116. CONSIDERATION OF ENRICHED ENROLLMENT RANDOMIZED WITHDRAWAL
METHODOLOGY.
(a) In General.--Not later than 2 years after the date of enactment
of this Act, the Secretary of Health and Human Services (referred to in
this section as the ``Secretary''), acting through the Commissioner of
Food and Drugs, shall convene a meeting of the Anesthetic and Analgesic
Drug Products Advisory Committee and the Drug Safety and Risk
Management Advisory Committee of the Food and Drug Administration to
review the use of the enriched enrollment randomized withdrawal
methodology in clinical trials of opioid analgesic drugs and consider
and make recommendations regarding the use of alternative clinical
study methodologies. In conducting such review, the Secretary shall
consider the report issued by the National Academy of Sciences under
subsection (c).
(b) Presentations.--If the Secretary allows for formal
presentations in support of the use of the enriched enrollment
randomized withdrawal methodology at the meeting described in
subsection (a), the Secretary shall also allow for equal time at such
meeting for presentations that are critical of such methodology.
(c) Nas Study and Report.--The Secretary shall seek to enter into a
contract with the National Academy of Sciences under which the National
Academy--
(1) conducts a study on the effectiveness of enriched
enrollment randomized withdrawal methodology in demonstrating
the efficacy of opioid analgesic drugs in treating chronic
pain; and
(2) not later than 1 year after the date of enactment of
this Act, submits a report on such study to the Secretary.
(d) Review of Opioid Analgesic Drugs.--In connection with the
meeting described in subsection (a), the Anesthetic and Analgesic Drug
Products Advisory Committee and the Drug Safety and Risk Management
Advisory Committee of the Food and Drug Administration shall review the
approved labeling and action package for approval (as described in
subsection (l)(2) of section 505 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 355)), on all opioid analgesic drugs approved
using enriched enrollment randomized withdrawal methodology under such
section 505 as of the date of such meeting. The findings from such
review shall be made publicly available on a website operated by the
Secretary, acting through the Commissioner of Food and Drugs.
(e) Definition of Opioid Analgesic Drug.--In this section, the term
``opioid analgesic drug'' means a drug that has a labeled indication
approved by the Food and Drug Administration to produce analgesia by
acting upon the body's opioid receptors.
SEC. 117. APPROVAL OF NEW OPIOID ANALGESIC DRUGS.
Section 505(c) of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 355(c)) is amended by adding at the end the following:
``(6) Notwithstanding any other provision of this section,
in making a determination to approve or deny an application
submitted under subsection (b) for an opioid analgesic drug,
the Secretary may consider whether such drug provides a
substantial improvement, in terms of greater safety or greater
effectiveness, or major contribution to patient care, compared
to an approved opioid analgesic drug. For purposes of this
paragraph, the term `opioid analgesic drug' means a drug that
is approved under this section to produce analgesia by acting
upon the body's opioid receptors.''.
SEC. 118. GUIDANCE ON DEVELOPING NON-ADDICTIVE MEDICAL PRODUCTS TO
TREAT PAIN OR ADDICTION.
Not later than 1 year after the date of enactment of this Act, the
Secretary of Health and Human Services shall issue draft guidance under
section 3001(b) of the SUPPORT for Patients and Communities Act (21
U.S.C. 355 note) to address non-addictive analgesics for chronic pain,
including the information required to be included in guidance documents
under paragraphs (1) through (4) of such section 3001(b).
SEC. 119. NATIONAL CHRONIC PAIN INFORMATION SYSTEM.
Part P of title III of the Public Health Service Act (42 U.S.C.
280g et seq.) is amended by adding at the end the following:
``SEC. 399V-8. CHRONIC PAIN RESEARCH.
``(a) In General.--The Secretary, in consultation with the Director
of the Centers for Disease Control and Prevention, the Director of the
National Institutes of Health, and other agencies as the Secretary
determines appropriate, shall--
``(1) utilize available Federal research data to clarify
the incidence and prevalence of chronic pain from any source,
including injuries, operations, and diseases and conditions;
``(2) identify gaps in the available research data and
collect deidentified population research data using medical
claims and survey data to fill gaps in available research data,
such as--
``(A) incidence and prevalence of specific pain
conditions;
``(B) demographics and other information, such as
age, race, ethnicity, gender, and geographic location;
``(C) the incidence and prevalence of known chronic
pain conditions, as well as diseases and conditions
that include or lead to pain;
``(D) risk factors that may be associated with
chronic pain conditions, such as genetic and
environmental risk factors and other information, as
appropriate;
``(E) diagnosis and progression markers;
``(F) both direct and indirect costs of illness;
``(G) the epidemiology of the conditions;
``(H) the detection, management, and treatment of
the conditions;
``(I) the epidemiology, detection, management, and
treatment of frequent secondary or co-occurring
conditions, such as depression, anxiety, and substance
use disorders;
``(J) the utilization of medical and social
services by patients with chronic pain conditions,
including the direct health care costs of pain
treatment, both traditional and alternative, and the
indirect costs (such as missed work, public and private
disability, and reduction in productivity); and
``(K) the effectiveness of evidence-based treatment
approaches on chronic pain conditions;
``(3) develop, in collaboration with individuals and
organizations with appropriate chronic pain expertise,
including patients or patient advocates, epidemiologists,
representatives of national voluntary health associations,
health information technology experts, clinicians, and research
scientists, standard definitions and approaches for population
research on chronic pain to efficiently promote greater
comparability of data; and
``(4) disseminate, pursuant to the public webpage under
subsection (b), and, as appropriate, to the public and to other
Federal departments and agencies, any findings, developed
population research standards, and available Federal data
sources related to chronic pain.
``(b) Dissemination.--The Secretary, acting through the Director of
the Centers for Disease Control and Prevention, shall establish a
public webpage, to be known as the Chronic Pain Information Hub, that--
``(1) aggregates and summarizes available Federal data
sources, indicators, and peer-reviewed research related to
chronic pain;
``(2) includes an up-to-date summary of complete, ongoing,
and planned data collection and analysis related to chronic
pain that is conducted and supported by the Centers for Disease
Control and Prevention; and
``(3) translates research findings into clinical tools and
resources, recommendations for closing research gaps, and
recommendations for population research standards for
researchers, with recommendations updated annually to
incorporate research findings from the prior year.
``(c) Conflicts of Interest.--If an individual or organization that
collaborates with the Secretary in carrying out subsection (a) receives
a payment or other transfer of value of a type described in section
1128G(a)(1)(A)(vi) of the Social Security Act from a manufacturer of a
drug (including a biological product) or device that would be required
to be disclosed pursuant to section 1128G(a)(1) of the Social Security
Act, if the individual or organization were a covered recipient or if
such disclosure were required upon request of or by designation on
behalf of a covered recipient pursuant to such section, the individual
or organization shall disclose to the Secretary information regarding
such payment or other transfer of value. The Secretary shall make such
disclosures publicly available.
``(d) Report.--Not later than 2 years after the date of the
enactment of the SUPPORT for Patients and Communities Reauthorization
Act, the Secretary shall submit a report to the Committee on Health,
Education, Labor, and Pensions of the Senate and the Committee on
Energy and Commerce of the House of Representatives concerning the
implementation of this section. Such report shall include information
on--
``(1) the development and maintenance of the Chronic Pain
Information Hub;
``(2) the information made available through the Chronic
Pain Information Hub;
``(3) the data gaps identified, and planned efforts to
address such gaps;
``(4) the process established for soliciting feedback from
collaborators; and
``(5) feedback received from collaborators.
``(e) Definition.--In this section, the term `chronic pain' means
persistent or recurrent pain lasting longer than 3 months.
``(f) Authorization of Appropriations.--To carry out this section,
there is authorized to be appropriated such sums as may be necessary
for each of fiscal years 2024 through 2028.''.
SEC. 120. REQUIREMENTS FOR ELECTRONIC-PRESCRIBING FOR CONTROLLED
SUBSTANCES UNDER GROUP HEALTH PLANS AND GROUP AND
INDIVIDUAL HEALTH INSURANCE COVERAGE.
(a) Public Health Service Act Amendment.--Section 2799A-7 of the
Public Health Service Act (42 U.S.C. 300gg-117) is amended by adding at
the end the following new subsection:
``(d) Requirements for Electronic-Prescribing for Controlled
Substances.--
``(1) In general.--Except as provided pursuant to paragraph
(2), for plan years beginning on or after January 1, 2026, a
group health plan and a health insurance issuer offering group
or individual health insurance coverage, with respect to a
participating provider, as defined in section 2799-1(a)(3),
shall have in place policies, subject to paragraphs (4) and
(5), that require any prescription for a schedule II, III, IV,
or V controlled substance (as defined by section 202 of the
Controlled Substances Act) covered by the plan or coverage that
is transmitted by such a participating provider for such a
participant, beneficiary, or enrollee be electronically
transmitted consistent with standards established under
paragraph (3) of section 1860D-4(e) of the Social Security Act,
under an electronic prescription drug program that meets
requirements that are substantially similar (as jointly
determined by the Secretary, the Secretary of Labor, and the
Secretary of the Treasury) to the requirements of paragraph (2)
of such section 1860D-4(e).
``(2) Exception for certain circumstances.--The Secretary,
the Secretary of Labor, and the Secretary of the Treasury shall
jointly, through rulemaking, specify circumstances and
processes by which the requirement under paragraph (1) may be
waived, with respect to a schedule II, III, IV, or V controlled
substance that is a prescription drug covered by a group health
plan or group or individual health insurance coverage offered
by a health insurance issuer, including in the case of--
``(A) a prescription issued when the participating
provider and dispensing pharmacy are the same entity;
``(B) a prescription issued that cannot be
transmitted electronically under the most recently
implemented version of the National Council for
Prescription Drug Programs SCRIPT Standard;
``(C) a prescription issued by a participating
provider who received a waiver (which may include a
waiver obtained pursuant to section 1860D-
4(e)(7)(B)(iii) of the Social Security Act) or a
renewal thereof for a period of time as determined by
the Secretary, the Secretary of Labor, and the
Secretary of the Treasury, not to exceed one year, from
the requirement to use electronic prescribing due to
demonstrated economic hardship, technological
limitations that are not reasonably within the control
of the participating provider, or other exceptional
circumstance demonstrated by the participating
provider;
``(D) a prescription issued by a participating
provider under circumstances in which, notwithstanding
the participating provider's ability to submit a
prescription electronically as required by this
subsection, such participating provider reasonably
determines that it would be impractical for the
individual involved to obtain substances prescribed by
electronic prescription in a timely manner, and such
delay would adversely impact the individual involved's
medical condition involved;
``(E) a prescription issued by a participating
provider prescribing a drug under a research protocol;
``(F) a prescription issued by a participating
provider for a drug for which the Food and Drug
Administration requires a prescription to contain
elements that are not able to be included in electronic
prescribing, such as a drug with risk evaluation and
mitigation strategies that include elements to assure
safe use;
``(G) a prescription issued for an individual who
receives hospice care or for a resident of a nursing
facility (as defined in section 1919(a) of the Social
Security Act);
``(H) a prescription issued under circumstances in
which electronic prescribing is not available due to
temporary technological or electrical failure, as
specified jointly by the Secretary, the Secretary of
Labor, and the Secretary of the Treasury through
rulemaking; and
``(I) a prescription issued by a participating
provider allowing for the dispensing of a non-patient
specific prescription pursuant to a standing order,
approved protocol for drug therapy, collaborative drug
management, or comprehensive medication management, in
response to a public health emergency or other
circumstances under which the participating provider
may issue a non-patient specific prescription.
``(3) Rules of construction.--
``(A) Verification.--Nothing in this subsection
shall be construed as requiring a dispenser to verify
that a participating provider, with respect to a
prescription for a schedule II, III, IV, or V
controlled substance that is a prescription drug
covered by a group health plan or group or individual
health insurance coverage offered by a health insurance
issuer, has a waiver (or is otherwise exempt) under
paragraph (2) from the requirement under paragraph (1).
``(B) Authority to dispense.--Nothing in this
subsection shall be construed as affecting the
authority of a group health plan or group or individual
health insurance coverage offered by a health insurance
issuer to cover, or the authority of a dispenser to
continue to dispense, a prescription drug if the
prescription for such drug is an otherwise valid
written, oral, or fax prescription that is consistent
with applicable law.
``(C) Patient choice.--Nothing in this subsection
shall be construed as affecting the ability of an
individual who is a participant, beneficiary, or
enrollee of a group health plan or group or individual
health insurance coverage offered by a health insurance
issuer and who is prescribed a schedule II, III, IV, or
V controlled substance that is a prescription drug
covered by the plan or coverage to designate a
particular dispenser to dispense a prescribed
controlled substance to the extent consistent with the
requirements under this subsection.
``(4) Regulations on policy requirements.--The Secretary,
the Secretary of Labor, and the Secretary of the Treasury shall
promulgate regulations specifying requirements for the policies
established by group health plans and health insurance issuers
under paragraph (1). Such regulations shall include
requirements for--
``(A) a uniform process by which plans and issuers
are required to set the e-prescribing requirements;
``(B) a process by which plans and issuers are
required to grant waivers and exceptions to
participating providers pursuant to paragraph (2); and
``(C) a mechanism for plans and issuers to
recognize waivers issued to participating providers
under part D of title XVIII of the Social Security Act,
pursuant to paragraph (2)(C).
``(5) Prohibitions.--The policies established pursuant to
paragraph (1) by a group health plan or health insurance issuer
offering group or individual health insurance coverage may
not--
``(A) require dispensers of a schedule II, III, IV,
or V controlled substance to confirm that the
prescription for the controlled substance was
electronically issued by a participating provider in
accordance with such policies, as described in
paragraph (1);
``(B) require dispensers of such controlled
substances to submit information or data beyond what is
otherwise required to process a prescription drug claim
in order to confirm a participating provider's
compliance with such policies;
``(C) reject, deny, or recoup reimbursement for a
prescription drug claim based on the format in which
the prescription was issued; or
``(D) require a participating provider to use a
specific vendor for electronic prescribing or a
specific electronic prescribing product or system.
``(6) Attestation of compliance.--Beginning on January 1,
2026, each group health plan and health insurance issuer
offering group or individual health insurance coverage shall
annually submit to the Secretary, the Secretary of Labor, and
the Secretary of the Treasury an attestation of compliance with
the requirements of this subsection.
``(7) Consultation requirement for rulemaking.--In
promulgating regulations to carry out this subsection, the
Secretary, the Secretary of the Labor, and the Secretary of the
Treasury shall jointly consult with dispensers of controlled
substances, State insurance regulators, and health care
practitioners.''.
(b) Employee Retirement Income Security Act of 1974 Amendment.--
Section 722 of the Employee Retirement Income Security Act of 1974 (29
U.S.C. 1185k) is amended by adding at the end the following new
subsection:
``(d) Requirements for Electronic-prescribing for Controlled
Substances.--
``(1) In general.--Except as provided pursuant to paragraph
(2), for plan years beginning on or after January 1, 2026, a
group health plan and a health insurance issuer offering group
health insurance coverage, with respect to a participating
provider, as defined in section 716(a)(3), shall have in place
policies, subject to paragraphs (4) and (5), that require any
prescription for a schedule II, III, IV, or V controlled
substance (as defined by section 202 of the Controlled
Substances Act) covered by the plan or coverage that is
transmitted by such a participating provider for such a
participant or beneficiary be electronically transmitted
consistent with standards established under paragraph (3) of
section 1860D-4(e) of the Social Security Act, under an
electronic prescription drug program that meets requirements
that are substantially similar (as jointly determined by the
Secretary, the Secretary of Health and Human Services, and the
Secretary of the Treasury) to the requirements of paragraph (2)
of such section 1860D-4(e).
``(2) Exception for certain circumstances.--The Secretary,
the Secretary of Health and Human Services, and the Secretary
of the Treasury shall jointly, through rulemaking, specify
circumstances and processes by which the requirement under
paragraph (1) may be waived, with respect to a schedule II,
III, IV, or V controlled substance that is a prescription drug
covered by a group health plan or group health insurance
coverage offered by a health insurance issuer, including in the
case of--
``(A) a prescription issued when the participating
provider and dispensing pharmacy are the same entity;
``(B) a prescription issued that cannot be
transmitted electronically under the most recently
implemented version of the National Council for
Prescription Drug Programs SCRIPT Standard;
``(C) a prescription issued by a participating
provider who received a waiver (which may include a
waiver obtained pursuant to section 1860D-
4(e)(7)(B)(iii) of the Social Security Act) or a
renewal thereof for a period of time as determined by
the Secretary, the Secretary of Health and Human
Services, and the Secretary of the Treasury, not to
exceed one year, from the requirement to use electronic
prescribing due to demonstrated economic hardship,
technological limitations that are not reasonably
within the control of the participating provider, or
other exceptional circumstance demonstrated by the
participating provider;
``(D) a prescription issued by a participating
provider under circumstances in which, notwithstanding
the participating provider's ability to submit a
prescription electronically as required by this
subsection, such participating provider reasonably
determines that it would be impractical for the
individual involved to obtain substances prescribed by
electronic prescription in a timely manner, and such
delay would adversely impact the individual's medical
condition involved;
``(E) a prescription issued by a participating
provider prescribing a drug under a research protocol;
``(F) a prescription issued by a participating
provider for a drug for which the Food and Drug
Administration requires a prescription to contain
elements that are not able to be included in electronic
prescribing, such as a drug with risk evaluation and
mitigation strategies that include elements to assure
safe use;
``(G) a prescription issued for an individual who
receives hospice care or for a resident of a nursing
facility (as defined in section 1919(a) of the Social
Security Act);
``(H) a prescription issued under circumstances in
which electronic prescribing is not available due to
temporary technological or electrical failure, as
specified jointly by the Secretary, the Secretary of
Health and Human Services, and the Secretary of the
Treasury through rulemaking; and
``(I) a prescription issued by a participating
provider allowing for the dispensing of a non-patient
specific prescription pursuant to a standing order,
approved protocol for drug therapy, collaborative drug
management, or comprehensive medication management, in
response to a public health emergency or other
circumstances under which the participating provider
may issue a non-patient specific prescription.
``(3) Rules of construction.--
``(A) Verification.--Nothing in this subsection
shall be construed as requiring a dispenser to verify
that a participating provider, with respect to a
prescription for a schedule II, III, IV, or V
controlled substance that is a prescription drug
covered by a group health plan or group or individual
health insurance coverage offered by a health insurance
issuer, has a waiver (or is otherwise exempt) under
paragraph (2) from the requirement under paragraph (1).
``(B) Authority to dispense.--Nothing in this
subsection shall be construed as affecting the
authority of a group health plan or group health
insurance coverage offered by a health insurance issuer
to cover, or the authority of a dispenser to continue
to dispense, a prescription drug if the prescription
for such drug is an otherwise valid written, oral, or
fax prescription that is consistent with applicable
law.
``(C) Patient choice.--Nothing in this subsection
shall be construed as affecting the ability of an
individual who is a participant or beneficiary of a
group health plan or group or individual health
insurance coverage offered by a health insurance issuer
and who is prescribed a schedule II, III, IV, or V
controlled substance that is a prescription drug
covered by the plan or coverage to designate a
particular dispenser to dispense a prescribed
controlled substance to the extent consistent with the
requirements under this subsection.
``(4) Regulations on policy requirements.--The Secretary,
the Secretary of Health and Human Services, and the Secretary
of the Treasury shall promulgate regulations specifying
requirements for the policies established by group health plans
and health insurance issuers under paragraph (1). Such
regulations shall include requirements for--
``(A) a uniform process by which plans and issuers
are required to set the e-prescribing requirements;
``(B) a process by which plans and issuers are
required to grant waivers and exceptions to
participating providers pursuant to paragraph (2); and
``(C) a mechanism for plans and issuers to
recognize waivers issued to participating providers
under part D of title XVIII of the Social Security Act,
pursuant to paragraph (2)(C).
``(5) Prohibitions.--The policies established pursuant to
paragraph (1) by a group health plan or health insurance issuer
offering group health insurance coverage may not--
``(A) require dispensers of a schedule II, III, IV,
or V controlled substance to confirm that the
prescription for the controlled substance was
electronically issued by a participating provider in
accordance with such policies, as described in
paragraph (1);
``(B) require dispensers of such controlled
substances to submit information or data beyond what is
otherwise required to process a prescription drug claim
in order to confirm a participating provider's
compliance with such policies;
``(C) reject, deny, or recoup reimbursement for a
prescription drug claim based on the format in which
the prescription was issued; or
``(D) require a participating provider to use a
specific vendor for electronic prescribing or a
specific electronic prescribing product or system.
``(6) Attestation of compliance.--Beginning on January 1,
2026, each group health plan and health insurance issuer
offering group health insurance coverage shall annually submit
to the Secretary, the Secretary of Health and Human Services,
and the Secretary of the Treasury an attestation of compliance
with the requirements of this subsection.
``(7) Consultation requirement for rulemaking.--In
promulgating regulations to carry out this subsection, the
Secretary, the Secretary of Health and Human Services, and the
Secretary of the Treasury shall jointly consult with dispensers
of controlled substances, State insurance regulators, and
health care practitioners.''.
(c) Internal Revenue Code of 1986 Amendment.--Section 9822 of the
Internal Revenue Code of 1986 is amended by adding at the end the
following new subsection:
``(d) Requirements for Electronic-Prescribing for Controlled
Substances.--
``(1) In general.--Except as provided pursuant to paragraph
(2), for plan years beginning on or after January 1, 2026, a
group health plan, with respect to a participating provider, as
defined in section 9816(a)(3), shall have in place policies,
subject to paragraphs (4) and (5), that require any
prescription for a schedule II, III, IV, or V controlled
substance (as defined by section 202 of the Controlled
Substances Act) covered by the plan that is transmitted by such
a participating provider for such a participant or beneficiary
be electronically transmitted consistent with standards
established under paragraph (3) of section 1860D-4(e) of the
Social Security Act, under an electronic prescription drug
program that meets requirements that are substantially similar
(as jointly determined by the Secretary, the Secretary of
Health and Human Services, and the Secretary of Labor) to the
requirements of paragraph (2) of such section 1860D-4(e).
``(2) Exception for certain circumstances.--The Secretary,
the Secretary of Health and Human Services, and the Secretary
of Labor shall jointly, through rulemaking, specify
circumstances and processes by which the requirement under
paragraph (1) may be waived, with respect to a schedule II,
III, IV, or V controlled substance that is a prescription drug
covered by a group health, including in the case of--
``(A) a prescription issued when the participating
provider and dispensing pharmacy are the same entity;
``(B) a prescription issued that cannot be
transmitted electronically under the most recently
implemented version of the National Council for
Prescription Drug Programs SCRIPT Standard;
``(C) a prescription issued by a participating
provider who received a waiver (which may include a
waiver obtained pursuant to section 1860D-
4(e)(7)(B)(iii) of the Social Security Act) or a
renewal thereof for a period of time as determined by
the Secretary, the Secretary of Health and Human
Services, and the Secretary of Labor, not to exceed one
year, from the requirement to use electronic
prescribing due to demonstrated economic hardship,
technological limitations that are not reasonably
within the control of the participating provider, or
other exceptional circumstance demonstrated by the
participating provider;
``(D) a prescription issued by a participating
provider under circumstances in which, notwithstanding
the participating provider's ability to submit a
prescription electronically as required by this
subsection, such participating provider reasonably
determines that it would be impractical for the
individual involved to obtain substances prescribed by
electronic prescription in a timely manner, and such
delay would adversely impact the individual's medical
condition involved;
``(E) a prescription issued by a participating
provider prescribing a drug under a research protocol;
``(F) a prescription issued by a participating
provider for a drug for which the Food and Drug
Administration requires a prescription to contain
elements that are not able to be included in electronic
prescribing, such as a drug with risk evaluation and
mitigation strategies that include elements to assure
safe use;
``(G) a prescription issued for an individual who
receives hospice care or for a resident of a nursing
facility (as defined in section 1919(a) of the Social
Security Act);
``(H) a prescription issued under circumstances in
which electronic prescribing is not available due to
temporary technological or electrical failure, as
specified jointly by the Secretary, the Secretary of
Health and Human Services, and the Secretary of Labor
through rulemaking; and
``(I) a prescription issued by a participating
provider allowing for the dispensing of a non-patient
specific prescription pursuant to a standing order,
approved protocol for drug therapy, collaborative drug
management, or comprehensive medication management, in
response to a public health emergency or other
circumstances under which the participating provider
may issue a non-patient specific prescription.
``(3) Rules of construction.--
``(A) Verification.--Nothing in this subsection
shall be construed as requiring a dispenser to verify
that a participating provider, with respect to a
prescription for a schedule II, III, IV, or V
controlled substance that is a prescription drug
covered by a group health plan, has a waiver (or is
otherwise exempt) under paragraph (2) from the
requirement under paragraph (1).
``(B) Authority to dispense.--Nothing in this
subsection shall be construed as affecting the ability
of a group health plan to cover, or the ability of a
dispenser to continue to dispense, a prescription drug
if the prescription for such drug is an otherwise valid
written, oral, or fax prescription that is consistence
with applicable laws and regulations.
``(C) Patient choice.--Nothing in this subsection
shall be construed as affecting the ability of an
individual who is a participant or beneficiary of a
group health plan and who is prescribed a schedule II,
III, IV, or V controlled substance that is a
prescription drug covered by the plan to designate a
particular dispenser to dispense a prescribed
controlled substance to the extent consistent with the
requirements under this subsection.
``(4) Regulations on policy requirements.--The Secretary,
the Secretary of Health and Human Services, and the Secretary
of Labor shall promulgate regulations specifying requirements
for the policies established by group health plans under
paragraph (1). Such regulations shall include requirements
for--
``(A) a uniform process by which plans are required
to set the e-prescribing requirements;
``(B) a process by which plans are required to
grant waivers and exceptions to participating providers
pursuant to paragraph (2); and
``(C) a mechanism for plans to recognize waivers
issued to participating providers under part D of title
XVIII of the Public Health Service Act, pursuant to
paragraph (2)(C).
``(5) Prohibitions.--The policies established pursuant to
paragraph (1) by a group health plan may not--
``(A) require dispensers of a schedule II, III, IV,
or V controlled substance to confirm that the
prescription for the controlled substance was
electronically issued by a participating provider in
accordance with such policies, as described in
paragraph (1);
``(B) require dispensers of such controlled
substances to submit information or data beyond what is
otherwise required to process a prescription drug claim
in order to confirm a participating provider's
compliance with such policies;
``(C) reject, deny, or recoup reimbursement for a
prescription drug claim based on the format in which
the prescription was issued; or
``(D) require a participating provider to use a
specific vendor for electronic prescribing or a
specific electronic prescribing product or system.
``(6) Attestation of compliance.--Beginning on January 1,
2026, each group health plan shall annually submit to the
Secretary, the Secretary of Health and Human Services, and the
Secretary of Labor an attestation of compliance with the
requirements of this subsection.
``(7) Consultation requirement for rulemaking.--In
promulgating regulations to carry out this subsection, the
Secretary, the Secretary of Health and Human Services, and the
Secretary of Labor shall jointly consult with dispensers of
controlled substances, State insurance regulators, and health
care practitioners.''.
(d) Update of Biometric Component of Multifactor Authentication.--
Not later than 1 year after the date of enactment of this Act, the
Attorney General shall finalize a regulation updating the requirements
for the biometric component of multifactor authentication with respect
to electronic prescriptions of controlled substances, as required under
section 2003(c) of the SUPPORT for Patients and Community Act (Public
Law 115-271).
TITLE II--TREATMENT
SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND POSTPARTUM
WOMEN.
Section 508 of the Public Health Service Act (42 U.S.C. 290bb-1) is
amended--
(1) in subsection (d)(11)(C), by striking ``providing
health services'' and inserting ``providing health care
services'';
(2) in subsection (g)--
(A) by inserting ``a plan describing'' after ``will
provide''; and
(B) by adding at the end the following: ``Such plan
may include a description of how such applicant will
target outreach to women disproportionately impacted by
maternal substance use disorder.''; and
(3) in subsection (s), by striking ``$29,931,000 for each
of fiscal years 2019 through 2023'' and inserting ``$38,931,000
for each of fiscal years 2024 through 2028''.
SEC. 202. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER TREATMENT
WORKFORCE.
Section 781(j) of the Public Health Service Act (42 U.S.C. 295h(j))
is amended by striking ``$25,000,000 for each of fiscal years 2019
through 2023'' and inserting ``$50,000,000 for each of fiscal years
2024 through 2028''.
SEC. 203. REGIONAL CENTERS OF EXCELLENCE IN SUBSTANCE USE DISORDER
EDUCATION.
Section 551 of the Public Health Service Act (42 U.S.C. 290ee-6) is
amended by striking subsection (f).
SEC. 204. MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING PROGRAM.
Section 756(f) of the Public Health Service Act (42 U.S.C. 294e-
1(f)) is amended to read as follows:
``(f) Authorization of Appropriations.--To carry out this section,
there is authorized to be appropriated the following:
``(1) $50,000,000 for fiscal year 2024, to be allocated as
follows:
``(A) For grants described in subsection (a)(1),
$15,000,000.
``(B) For grants described in subsection (a)(2),
$15,000,000.
``(C) For grants described in subsection (a)(3),
$10,000,000.
``(D) For grants described in subsection (a)(4),
$10,000,000.
``(2) $55,000,000 for fiscal year 2025, to be allocated as
follows:
``(A) For grants described in subsection (a)(1),
$16,500,000.
``(B) For grants described in subsection (a)(2),
$16,500,000.
``(C) For grants described in subsection (a)(3),
$11,000,000.
``(D) For grants described in subsection (a)(4),
$11,000,000.
``(3) $60,000,000 for fiscal year 2026, to be allocated as
follows:
``(A) For grants described in subsection (a)(1),
$18,000,000.
``(B) For grants described in subsection (a)(2),
$18,000,000.
``(C) For grants described in subsection (a)(3),
$12,000,000.
``(D) For grants described in subsection (a)(4),
$12,000,000.
``(4) $65,000,000 for fiscal year 2027, to be allocated as
follows:
``(A) For grants described in subsection (a)(1),
$19,500,000.
``(B) For grants described in subsection (a)(2),
$19,500,000.
``(C) For grants described in subsection (a)(3),
$13,000,000.
``(D) For grants described in subsection (a)(4),
$13,000,000.
``(5) $75,000,000 for fiscal year 2028, to be allocated as
follows:
``(A) For grants described in subsection (a)(1),
$22,500,000.
``(B) For grants described in subsection (a)(2),
$22,500,000.
``(C) For grants described in subsection (a)(3),
$15,000,000.
``(D) For grants described in subsection (a)(4),
$15,000,000.''.
SEC. 205. GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER TREATMENT.
Section 3203 of the SUPPORT for Patients and Communities Act (21
U.S.C. 823 note) is amended--
(1) by striking subsection (b); and
(2) by striking ``In General--The Secretary'' and inserting
the following:
``The Secretary''.
SEC. 206. GRANTS TO IMPROVE TRAUMA SUPPORT SERVICES AND MENTAL HEALTH
CARE FOR CHILDREN AND YOUTH IN EDUCATIONAL SETTINGS.
Section 7134 of the SUPPORT for Patients and Communities Act (42
U.S.C. 280h-7) is amended--
(1) in subsection (a), by striking ``tribal'' and inserting
``Tribal'';
(2) in subsection (c)--
(A) in paragraph (1), by inserting ``early
intervention,'' after ``screening,'';
(B) in paragraph (3)--
(i) in the matter preceding subparagraph
(A), by inserting ``other staff,'' after
``support personnel,''; and
(ii) in subparagraph (A), by striking
``social and emotional learning'' and inserting
``developmentally appropriate practices''; and
(C) in paragraph (5), by inserting ``reduce stigma
associated with mental health care and'' after
``efforts to'';
(3) in subsection (d)--
(A) in paragraph (4)--
(i) in subparagraph (A), by striking ``;
and'' and inserting a semicolon;
(ii) in subparagraph (B)--
(I) by striking ``tribal
organizations as appropriate, other
school personnel'' and inserting
``Tribal organizations as appropriate,
other staff''; and
(II) by striking the period and
inserting ``; and''; and
(iii) by adding at the end the following:
``(C) parents and guardians will be informed of
what trauma support services and mental health care are
available to their students and what services and care
their students receive, in accordance with the parental
consent requirements under subsection (h)(2).''; and
(B) by adding at the end the following:
``(7) A plan for sustaining the program following the end
of the award period.'';
(4) in subsection (f)(1), by inserting ``, which shall
include a description of how the school obtains consent from
the student's parent or guardian for the provision of trauma
support services and mental health care'' after ``this
section'';
(5) in subsection (g), by striking ``tribal'' and inserting
``Tribal'';
(6) in subsection (h)--
(A) in the subsection heading, by inserting ``;
Application of Certain Provisions'' after
``Construction'';
(B) by striking ``tribal'' each place it appears
and inserting ``Tribal'';
(C) by redesignating paragraphs (1) and (2) as
subparagraphs (A) and (B), respectively, and adjusting
the margins accordingly;
(D) by striking ``Nothing in this section'' and
inserting the following:
``(1) In general.--Nothing in this section''; and
(E) by adding at the end the following:
``(2) Application of provisions.--
``(A) Rules.--Section 4001 of the Elementary and
Secondary Education Act of 1965 (not including the
exception under subsection (a)(2)(B)(i) of such
section) shall apply to an entity receiving a grant,
contract, or cooperative agreement under this section
in the same manner as such section 4001 applies to an
entity receiving funding under title IV of such Act.
``(B) Privacy protections.--Any education record of
a student collected or maintained under subsection
(c)(4) shall have the protections required for
education records under section 444 of the General
Education Provisions Act.''.
(7) in subsection (k)--
(A) by redesignating paragraphs (5) through (11) as
paragraphs (6) through (12), respectively; and
(B) by inserting after paragraph (4) the following:
``(5) Other staff.--The term `other staff' has the meaning
given such term in section 8101 of the Elementary and Secondary
Education Act of 1965.''; and
(8) in subsection (l), by striking ``2019 through 2023''
and inserting ``2024 through 2028''.
SEC. 207. DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING PROGRAMS FOR
SUBSTANCE USE DISORDER PATIENT RECORDS.
Section 7053 of the SUPPORT for Patients and Communities Act (42
U.S.C. 290dd-2 note) is amended by striking subsection (e).
SEC. 208. TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED
IDENTIFICATION, REFERRAL, AND SUPPORT.
Section 7132 of the SUPPORT for Patients and Communities Act
(Public Law 115-271; 132 Stat. 4046) is amended--
(1) in subsection (b)(1)--
(A) by redesignating subparagraph (CC) as
subparagraph (DD); and
(B) by inserting after subparagraph (BB) the
following:
``(CC) The Administration for Community Living.'';
(2) in subsection (d)(1), in the matter preceding
subparagraph (A), by inserting ``, developmental disability
service providers'' before ``, individuals who are''; and
(3) in subsection (i), by striking ``2023'' and inserting
``2028''.
SEC. 209. PROGRAM TO SUPPORT COORDINATION AND CONTINUATION OF CARE FOR
DRUG OVERDOSE PATIENTS.
Section 7081 of the SUPPORT for Patients and Communities Act (42
U.S.C. 290dd-4) is amended by striking subsection (f).
SEC. 210. REGULATIONS RELATING TO SPECIAL REGISTRATION FOR
TELEMEDICINE.
Not later than 1 year after the date of enactment of this Act, the
Attorney General, in consultation with the Secretary of Health and
Human Services, shall promulgate the final regulations required under
section 311(h)(2) of the Controlled Substances Act (21 U.S.C.
831(h)(2)).
SEC. 211. MENTAL HEALTH PARITY.
(a) In General.--Not later than January 1, 2025, the Inspector
General of the Department of Labor, in coordination with the Inspector
General of the Department of Health and Human Services, shall report to
the Committee on Health, Education, Labor, and Pensions of the Senate
and the Committee on Energy and Commerce and the Committee on Education
and the Workforce of the House of Representatives on the following:
(1) The non-quantitative treatment limit (referred to in
this section as ``NQTL'') requirements with respect to mental
health and substance use disorder benefits under group health
plans and health insurance issuers under section 2726(a)(8) of
the Public Health Service Act (42 U.S.C. 300gg-26(a)(8)),
section 712(a)(8) of the Employee Retirement Income Security
Act of 1974 (29 U.S.C. 1185a(a)(8)), and section 9812(a)(8) of
the Internal Revenue Code of 1986 (referred to in this section
as the ``NQTL comparative analysis requirements''), and the
requirements for the Secretary of Health and Human Services,
the Secretary of Labor, and the Secretary of the Treasury to
issue regulations, a compliance program guide, and additional
guidance documents and tools providing guidance relating to
mental health parity requirements under section 2726(a) of the
Public Health Service Act (42 U.S.C. 300gg-26(a)), section
712(a) of the Employee Retirement Income Security Act of 1974
(29 U.S.C. 1185a(a)), and section 9812(a) of the Internal
Revenue Code of 1986.
(2) With respect to the NQTL comparative analysis
requirements described in paragraph (1), an analysis of the
actions taken by the Secretary of Labor, the Secretary of the
Treasury, and the Secretary of Health and Human Services to
provide guidance to ensure that group health plans and health
insurance issuers can fully comply with mental health parity
requirements under section 2726 of the Public Health Service
Act (42 U.S.C. 300gg-26), section 712 of the Employee
Retirement Income Security Act of 1974 (29 U.S.C. 1185a), and
section 9812 of the Internal Revenue Code of 1986 and the NQTL
comparative analysis requirements described in paragraph (1),
including an analysis of--
(A) the extent to which the Secretary of Labor, the
Secretary of the Treasury, and the Secretary of Health
and Human Services have fulfilled the requirement under
section 203(b) of division BB of the Consolidated
Appropriations Act, 2021 (Public Law 116-260) to issue
the specific guidance and regulations pertaining to the
requirements for group health plans and health
insurance issuers to demonstrate compliance with the
NQTL comparative analysis requirements; and
(B) whether sufficient guidance and examples from
the Department of Labor and Department of Health and
Human Services, and the Department of the Treasury
exist to guide and assist group health plans and health
insurance issuers in complying with the requirements to
demonstrate compliance with mental health parity NQTL
comparative analysis requirements/under such sections
2726(a)(8), 712(a)(8), and 9812(a)(8).
(3) A review of the enforcement processes of the Department
of Labor and the Department of Health and Human Services to
evaluate the consistency of interpretation of the requirements
under section 2726(a)(8) of the Public Health Service Act (42
U.S.C. 300gg-26(a)(8)), section 712(a)(8) of the Employee
Retirement Income Security Act of 1974 (29 U.S.C. 1185a(a)(8)),
and section 9812(a)(8) of the Internal Revenue Code of 1986, in
particular with respect to processes utilized for enforcement,
actions or inactions that constitute noncompliance, and
avoidance among the agencies of duplication of enforcement,
including an evaluation of compliance with section 104 of the
Health Insurance Portability and Accountability Act of 1996
(Public Law 104-191).
(4) A review of the implementation, by the Department of
Labor, Department of Health and Human Services, and Department
of the Treasury, of mental health parity requirements under
section 2726 of the Public Health Service Act (42 U.S.C. 300gg-
26), section 712 of the Employee Retirement Income Security Act
of 1974 (29 U.S.C. 1185a), and section 9812 of the Internal
Revenue Code of 1986, including all such requirements in effect
through the enactment of the Mental Health Parity Act of 1996
(Public Law 104-204), the Paul Wellstone and Pete Domenici
Mental Health Parity and Addiction Equity Act of 2008 (Public
Law 110-460), the 21st Century Cures Act (Public Law 114-255),
and the Consolidated Appropriations Act, 2023 (Public Law 117-
328) (including any amendments made by such Acts), and
including with respect to the timing of all actions, delays of
any actions, reasons for any such delays, mandated requirements
that were met only once but not each time such requirements
were mandated.
(b) Definitions.--In this section, the terms ``group health plan''
and ``health insurance issuer'' have the meanings given such terms in
section 733 of the Employee Retirement Income Security Act of 1974 (29
U.S.C. 1191b).
SEC. 212. STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS MENTAL
ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCE.
(a) Review of Use of Certain Funding.--Not later than 1 year after
the date of enactment of this Act, the Secretary of Health and Human
Services, acting through the Assistant Secretary for Mental Health and
Substance Use, shall conduct a review of the use by States of funds
made available under the Community Mental Health Services Block Grant
program under subpart I of part B of title XIX of the Public Health
Service Act (42 U.S.C. 300x et seq.) for First Episode Psychosis
activities. Such review shall consider the following:
(1) How the States use funds for evidence-based treatments
and services, such as coordinated specialty care, according to
the standard of care for individuals with early serious mental
illness, including the comprehensiveness of such treatments to
include all aspects of the recommended intervention.
(2) How State mental health departments coordinate with
State Medicaid departments in the delivery of the treatments
and services described in paragraph (1).
(3) The percentage of the State funding under the block
grant program that is applied toward early serious mental
illness, and funding in excess of, or under, 10 percent of the
amount of the grant, broken down by State.
(4) The percentage of funds expended by States through such
block grant program specifically on First Episode Psychosis, to
the extent such information is available.
(5) How many individuals are served by the expenditures
described in paragraphs (3) and (4), on a per-capita basis.
(6) How the funds are used to reach underserved
populations, including rural populations and racial and ethnic
minority populations.
(b) Report and Guidance.--
(1) Report.--Not later than 6 months after the completion
of the review under subsection (a), the Secretary of Health and
Human Services, acting through the Assistant Secretary for
Mental Health and Substance Use, shall submit to the Committee
on Appropriations, the Committee on Health, Education, Labor,
and Pensions, and the Committee on Finance of the Senate and to
the Committee on Appropriations and the Committee on Energy and
Commerce of the House of Representatives a report on the
findings made as a result of the review conducted under
subsection (a). Such report shall include any recommendations
with respect to any changes to the Community Mental Health
Services Block Grant program under subpart I of part B of title
XIX of the Public Health Service Act (42 U.S.C. 300x et seq.),
including the set-aside required for First Episode Psychosis,
that would facilitate improved outcomes for the targeted
population involved.
(2) Guidance.--Not later than 1 year after the date on
which the report is submitted under paragraph (1), the
Secretary of Health and Human Services, acting through the
Assistant Secretary for Mental Health and Substance Use, shall
update the guidance provided to States under the Community
Mental Health Services Block Grant program based on the
findings and recommendations of the report.
(c) Additional Guidance.--The Director of the National Institute of
Mental Health shall coordinate with the Assistant Secretary for Mental
Health and Substance Use in providing guidance to State grantees and
provider subgrantees about research advances in the delivery of
services for First Episode Psychosis under the Community Mental Health
Services Block Grant program.
(d) Guidance for States Relating to Health Care Services and
Interventions for Individuals With Serious Mental Illness and Children
With Serious Emotional Disturbance.--Not later than 2 years after the
date of enactment of this Act, the Assistant Secretary for Mental
Health and Substance Use, jointly with the Administrator of the Centers
for Medicare & Medicaid Services and the Director of the National
Institute of Mental Health--
(1) shall provide updated guidance to States concerning the
manner in which Federal funding provided to States through
programs administered by such agencies, including the Community
Mental Health Services Block Grant program under subpart I of
part B of title XIX of the Public Health Service Act (42 U.S.C.
300x et seq.), may be coordinated to provide evidence-based
health care services such as coordinated specialty care to
individuals with serious mental illness and serious emotional
disturbance, and interventions for individuals with early
serious mental illness, including First Episode Psychosis; and
(2) may streamline relevant State reporting requirements if
such streamlining would result in making it easier for States
to coordinate funding under the programs described in paragraph
(1) to improve treatments for individuals with serious mental
illness and serious emotional disturbance.
SEC. 213. IMPROVING ACCESS TO ADDICTION MEDICINE PROVIDERS.
Section 597 of the Public Health Service Act (42 U.S.C. 290ll) is
amended--
(1) in subsection (a)(1), by inserting ``diagnosis,'' after
``related to''; and
(2) in subsection (b), by inserting ``addiction medicine,''
after ``psychiatry,''.
SEC. 214. ROUNDTABLE ON USING HEALTH INFORMATION TECHNOLOGY TO IMPROVE
MENTAL HEALTH AND SUBSTANCE USE CARE OUTCOMES.
(a) Roundtable.--Not later than 180 days after the date of
enactment of this Act, the Office of the National Coordinator for
Health Information Technology shall convene a public roundtable to
examine how the expanded use of electronic health records among mental
health and substance use service providers can improve outcomes for
patients in mental health and substance use settings and how best to
increase electronic health record adoption among such providers.
(b) Participants.--The National Coordinator for Health Information
Technology shall ensure that the participants in the roundtable under
subsection (a) include private and public sector stakeholders,
including patients, providers (including providers of inpatient
services and providers of outpatient services), and representatives of
payors, health information exchanges, professional associations, health
information technology vendors, health information technology
certification organizations, and State and Federal agencies.
(c) Report.--Not later than 180 days after the conclusion of the
public stakeholder roundtable under subsection (a), the Office of the
National Coordinator for Health Information Technology shall submit to
the Committee on Health, Education, Labor, and Pensions of the Senate
and the Committee on Energy and Commerce of the House of
Representatives a report outlining information gathered from the
roundtable under subsection (a). Such report shall include an
examination of--
(1) recommendations from the roundtable participants;
(2) unique considerations for using electronic health
record systems in mental health and substance use treatment
settings;
(3) unique considerations for developers of health
information technology relating to certification of electronic
health records for use in mental health and substance use
treatment settings where the applicable health information
technology is not currently subject to certification
requirements;
(4) current usage of electronic health records by mental
health and substance use disorder service providers, and the
scope and magnitude of such providers that do not use
electronic health record systems;
(5) examples of how electronic health record systems enable
coordinated care and care management;
(6) how electronic health record systems further
appropriate patient and provider access to secure, usable
electronic information exchange;
(7) how electronic health record systems can be connected
to or support existing systems, which may include the 988
crisis line, mobile crisis response systems, and co-responder
programs, to facilitate connectivity, response, and integrated
care;
(8) any existing programs to support greater adoption of
electronic health record systems among mental health and
substance use service providers;
(9) any limitations to greater adoption of electronic
health record systems among mental health and substance use
service providers;
(10) the costs of adoption of electronic health record
systems by mental health and substance use disorder service
providers; and
(11) best practices implemented by States and by other
entities to support adoption of use of electronic health
records among mental health and substance use disorder service
providers.
SEC. 215. PEER-TO-PEER MENTAL HEALTH SUPPORT.
(a) In General.--The Assistant Secretary for Mental Health and
Substance Use (referred to in this section as the ``Assistant
Secretary''), in consultation with the Secretary of Education, may, as
appropriate and within a relevant existing program, carry out a pilot
program and make awards, on a competitive basis, to eligible entities
to support evidence-based mental health peer support activities for
students enrolled in secondary schools (as such term is defined in
section 8101 of the Elementary and Secondary Education Act of 1965 (20
U.S.C. 7801)).
(b) Eligibility.--To be eligible to receive an award under this
section, an entity shall--
(1) be a State, political subdivision of a State,
territory, or Indian Tribe or Tribal organization (as such
terms are defined in section 4 of the Indian Self-Determination
and Education Assistance Act (25 U.S.C. 5304)); and
(2) submit to the Assistant Secretary an application at
such time, in such manner, and containing such information as
the Assistant Secretary may require, including a description of
how the entity will measure and evaluate progress of the
program in improving student mental health outcomes.
(c) Use of Amounts.--
(1) In general.--Subject to paragraph (2), an eligible
entity may use amounts provided under this section to implement
or operate evidence-based mental health peer support activities
in 1 or more secondary schools (as such term is defined in
section 8101 of the Elementary and Secondary Education Act of
1965 (20 U.S.C. 7801)) within the jurisdiction of such eligible
entity, which may include providing training, as appropriate,
to students, adult supervisors, and other appropriate
individuals to improve the early identification of, response
to, and recovery supports for mental health and substance use
challenges, reduce associated risks, and promote resiliency.
(2) Program oversight.--An eligible entity shall ensure
that mental health peer support activities under paragraph (1)
are overseen by a school-based mental health professional.
(3) FERPA.--Any education records of the student collected
or maintained under this section shall have the protections
provided in section 444 of the General Education Provisions Act
(20 U.S.C. 1232g).
(d) Evaluation; Report.--
(1) Evaluation.--The Assistant Secretary shall carry out an
evaluation to measure the efficacy of the program under this
section. The evaluation shall--
(A) measure participation rates in mental health
peer support activities, including any associated
trends;
(B) describe the specific trainings provided, or
other activities carried out under the pilot program;
(C) assess whether such mental health peer support
activities impacted mental health outcomes of
participating students; and
(D) measure the effectiveness of the pilot program
in connecting students to professional mental health
services compared to other evidence-based strategies.
(2) Report.--The Assistant Secretary shall prepare and
submit to the Committee on Health, Education, Labor, and
Pensions of the Senate and the Committees on Energy and
Commerce and Education and the Workforce of the House of
Representatives a report containing the results of the
evaluation conducted under paragraph (1).
(e) Technical Assistance.--The Assistant Secretary, in coordination
with the Secretary of Education, shall provide technical assistance to
eligible entities applying for and receiving an award under this
section, including the identification and dissemination of best
practices for mental health peer support programs for students.
(f) Rule of Construction.--Section 4001 of the Elementary and
Secondary Education Act of 1965 (20 U.S.C. 7101) shall apply to an
entity receiving a grant, contract, or cooperative agreement under this
section in the same manner as such section applies to an entity
receiving funding under title IV of such Act, except that section
4001(a)(2)(B)(i) of such Act shall not apply.
(g) Sunset.--This section shall terminate on September 30, 2028.
SEC. 216. KID PROOF PILOT PROGRAM.
(a) In General.--The Assistant Secretary for Mental Health and
Substance Use (referred to in this section as the ``Assistant
Secretary''), may, as appropriate and within a relevant existing
program, carry out a pilot program and make awards, on a competitive
basis, to eligible entities to prevent, or reduce the risk of, suicide
and drug overdose by children, adolescents, and young adults, including
by addressing the misuse of lethal means commonly used in overdose or
suicide.
(b) Eligibility.--To be eligible to receive an award under this
section, an entity shall--
(1) be a State, political subdivision of a State,
territory, or Indian Tribe or Tribal organization (as such
terms are defined in section 4 of the Indian Self-Determination
and Education Assistance Act (25 U.S.C. 5304)); and
(2) submit to the Assistant Secretary an application at
such time, in such manner, and containing such information as
the Assistant Secretary may require, including a description of
the geographic location and settings in which such entity
proposes to carry out activities under such award and the
demonstrated need of such geographic location and settings.
(c) Use of Funds.--An eligible entity shall use amounts provided
under this section to implement evidence-based practices to prevent, or
reduce the risk of, overdose and suicide among children, adolescents,
and young adults, including promoting education and awareness among
parents or legal guardians on relevant best practices and providing
appropriate supplies to parents or legal guardians to prevent, or
reduce the risk of, the misuse of lethal means commonly used in
overdose or suicide.
(d) Partnerships.--Recipients of funding under this section may
partner with health care facilities to carry out activities under
subsection (c).
(e) Evaluation; Report.--
(1) Evaluation.--Not later than 2 years after the date on
which awards under this section are first issued, the Assistant
Secretary shall carry out an evaluation to measure the efficacy
of the program under this section. The evaluation shall
include--
(A) a description of any specific education and
awareness activities carried out through the pilot
program under this section;
(B) the number and types of supplies provided to
parents or legal guardians to prevent, or reduce the
risk of, the misuse of lethal means commonly used in
overdose or suicide; and
(C) an assessment of the efficacy of the pilot
program in preventing, or reducing the risk of,
overdose and suicide.
(2) Report.--The Assistant Secretary shall prepare and
submit to the Committee on Health, Education, Labor, and
Pensions of the Senate and the Committee on Energy and Commerce
of the House of Representatives a report containing the results
of the evaluation conducted under paragraph (1).
(f) Sunset.--This section shall terminate on September 30, 2028.
TITLE III--RECOVERY
SEC. 301. YOUTH PREVENTION AND RECOVERY.
Section 7102(c) of the SUPPORT for Patients and Communities Act (42
U.S.C. 290bb-7a(c)) (as amended by section 113(a)) is amended--
(1) in paragraph (2)--
(A) in subparagraph (A)--
(i) in clause (i)--
(I) by inserting ``, or a consortia
of local educational agencies,'' after
``a local educational agency''; and
(II) by striking ``high schools''
and inserting ``secondary schools'';
and
(ii) in clause (vi), by striking ``tribe,
or tribal'' and inserting ``Tribe, or Tribal'';
(B) by amending subparagraph (E) to read as
follows:
``(E) Indian tribe; tribal organization.--The terms
`Indian Tribe' and `Tribal organization' have the
meanings given such terms in section 4 of the Indian
Self-Determination and Education Assistance Act (25
U.S.C. 5304).'';
(C) by redesignating subparagraph (K) as
subparagraph (L); and
(D) by inserting after subparagraph (J) the
following:
``(K) Secondary school.--The term `secondary
school' has the meaning given such term in section 8101
of the Elementary and Secondary Education Act of 1965
(20 U.S.C. 7801).'';
(2) in paragraph (3)(A), in the matter preceding clause
(i)--
(A) by striking ``and abuse''; and
(B) by inserting ``at increased risk for substance
misuse'' after ``specific populations'';
(3) in paragraph (4)--
(A) in the matter preceding subparagraph (A), by
striking ``Indian tribes'' and inserting ``Indian
Tribes'';
(B) in subparagraph (A), by striking ``and abuse'';
and
(C) in subparagraph (B), by striking ``peer
mentoring'' and inserting ``peer-to-peer support'';
(4) in paragraph (5), by striking ``tribal'' and inserting
``Tribal'';
(5) in paragraph (6)(A)--
(A) in clause (iv), by striking ``; and'' and
inserting a semicolon; and
(B) by adding at the end the following:
``(vi) a plan to sustain the activities
carried out under the grant program, after the
grant program has ended; and'';
(6) in paragraph (8), by striking ``2022'' and inserting
``2027''; and
(7) by amending paragraph (9) to read as follows:
``(9) Authorization of appropriations.--To carry out this
subsection, there are authorized to be appropriated $10,000,000
for fiscal year 2024, $12,000,000 for fiscal year 2025,
$14,000,000 for fiscal year 2026, $16,000,000 for fiscal year
2027, and $18,000,000 for fiscal year 2028.''.
SEC. 302. COMPREHENSIVE OPIOID RECOVERY CENTERS.
Section 552 of the Public Health Service Act (42 U.S.C. 290ee-7) is
amended--
(1) in subsection (d)(2)--
(A) in the matter preceding subparagraph (A), by
striking ``and in such manner'' and inserting ``, in
such manner, and containing such information and
assurances''; and
(B) in subparagraph (A), by striking ``is capable
of coordinating with other entities to carry out'' and
inserting ``has the demonstrated capability to carry
out, through referral or contractual arrangements'';
(2) in subsection (h)--
(A) by redesignating paragraphs (1) through (4) as
subparagraphs (A) through (D), respectively, and
adjusting the margins accordingly;
(B) by striking ``With respect to'' and inserting
the following:
``(1) In general.--With respect to''; and
(C) by adding at the end the following:
``(2) Additional reporting for certain eligible entities.--
An entity carrying out activities described in subsection (g)
through referral or contractual arrangements shall include in
the submissions required under paragraph (1) information
related to the status of such referrals or contractual
arrangements, including an assessment of whether such referrals
or contractual arrangements are supporting the ability of such
entity to carry out such activities.''; and
(3) in subsection (j), by striking ``2019 through 2023''
and inserting ``2024 through 2028''.
SEC. 303. BUILDING COMMUNITIES OF RECOVERY.
Section 547(f) of the Public Health Service Act (42 U.S.C. 290ee-
2(f)) is amended by striking ``$5,000,000 for each of fiscal years 2019
through 2023'' and inserting ``$16,000,000 for each of fiscal years
2024 through 2028''.
SEC. 304. PEER SUPPORT TECHNICAL ASSISTANCE CENTER.
Section 547A of the Public Health Service Act (42 U.S.C. 290ee-2a)
is amended--
(1) in subsection (b)(4), by striking ``building; and'' and
inserting the following: ``building, such as--
``(A) professional development of peer support
specialists; and
``(B) making recovery support services available in
nonclinical settings; and'';
(2) by redesignating subsections (d) and (e) as subsections
(e) and (f), respectively;
(3) by inserting after subsection (c) the following:
``(d) Pilot Program.--
``(1) In general.--The Secretary shall carry out a pilot
program to establish one regional technical assistance center
(referred to in this subsection as the `Regional Center') to
assist the Center in carrying out activities described in
subsection (b) within the geographic region of such Regional
Center in a manner that is tailored to the needs of such
region.
``(2) Evaluation.--Not later than 4 years after the date of
enactment of the SUPPORT for Patients and Communities
Reauthorization Act, the Secretary shall evaluate the
activities of the Regional Center and submit to the Committee
on Health, Education, Labor, and Pensions of the Senate and the
Committee on Energy and Commerce of the House of
Representatives a report on the findings of such evaluation,
including--
``(A) a description of the distinct roles and
responsibilities of the Regional Center and the Center;
``(B) available information relating to the
outcomes of the pilot program under this subsection,
such as any impact the Regional Center had on the
operations and efficiency of the Center relating to
requests for technical assistance and support within
the region of such Regional Center;
``(C) a description of any gaps or areas of
duplication relating to the activities of the Regional
Center and the Center within such region; and
``(D) recommendations relating to the modification,
expansion, or termination of the pilot program under
this subsection.
``(3) Termination.--This subsection shall terminate on
September 30, 2028.''; and
(4) in subsection (f), as so redesignated, by striking
``$1,000,000 for each of fiscal years 2019 through 2023'' and
inserting ``$2,000,000 for each of fiscal years 2024 through
2028''.
SEC. 305. CAREER ACT.
(a) In General.--Section 7183 of the SUPPORT for Patients and
Communities Act (42 U.S.C. 290ee-8) is amended--
(1) in the section heading, by inserting ``; treatment,
recovery, and workforce support grants'' after ``career act'';
(2) in subsection (b), by inserting ``each'' before ``for a
period'';
(3) in subsection (c)--
(A) in paragraph (1), by striking ``the rates
described in paragraph (2)'' and inserting ``the
average rates for calendar years 2018 through 2022
described in paragraph (2)''; and
(B) by amending paragraph (2) to read as follows:
``(2) Rates.--The rates described in this paragraph are the
following:
``(A) The highest age-adjusted average rates of
drug overdose deaths for calendar years 2018 through
2022 based on data from the Centers for Disease Control
and Prevention, including, if necessary, provisional
data for calendar year 2022.
``(B) The highest average rates of unemployment for
calendar years 2018 through 2022 based on data provided
by the Bureau of Labor Statistics.
``(C) The lowest average labor force participation
rates for calendar years 2018 through 2022 based on
data provided by the Bureau of Labor Statistics.'';
(4) in subsection (g)--
(A) in each of paragraphs (1) and (3), by
redesignating subparagraphs (A) and (B) as clauses (i)
and (ii), respectively, and adjusting the margins
accordingly;
(B) by redesignating paragraphs (1) through (3) as
subparagraphs (A) through (C), respectively, and
adjusting the margins accordingly;
(C) in the matter preceding subparagraph (A) (as so
redesignated), by striking ``An entity'' and inserting
the following:
``(1) In general.--An entity''; and
(D) by adding at the end the following:
``(2) Transportation services.--An entity receiving a grant
under this section may use not more than 5 percent of the funds
for providing transportation for individuals to participate in
an activity supported by a grant under this section, which
transportation shall be to or from a place of work or a place
where the individual is receiving career and technical
education or job training services or receiving services
directly linked to treatment of or recovery from a substance
use disorder.
``(3) Limitation.--The Secretary may not require an entity
to, or give priority to an entity that plans to, use the funds
of a grant under this section for activities that are not
specified in this subsection.'';
(5) in subsection (i)(2), by inserting ``, which shall
include employment and earnings outcomes described in
subclauses (I) and (III) of section 116(b)(2)(A)(i) of the
Workforce Innovation and Opportunity Act (29 U.S.C.
3141(b)(2)(A)(i)) with respect to the participation of such
individuals with a substance use disorder in programs and
activities funded by the grant under this section'' after
``subsection (g)'';
(6) in subsection (j)--
(A) in paragraph (1), by inserting ``for grants
awarded prior to the date of enactment of the SUPPORT
for Patients and Communities Reauthorization Act''
after ``grant period under this section''; and
(B) in paragraph (2)--
(i) in the matter preceding subparagraph
(A), by striking ``2 years after submitting the
preliminary report required under paragraph
(1)'' and inserting ``September 30, 2028''; and
(ii) in subparagraph (A), by striking
``(g)(3)'' and inserting ``(g)(1)(C)''; and
(7) in subsection (k), by striking ``$5,000,000 for each of
fiscal years 2019 through 2023'' and inserting ``$12,000,000
for each of fiscal years 2024 through 2028''.
(b) Clerical Amendment.--The table of contents in section 1(b) of
the SUPPORT for Patients and Communities Act (Public Law 115-271; 132
Stat. 3894) is amended by striking the item relating to section 7183
and inserting the following:
``Sec. 7183. CAREER Act; treatment, recovery, and workforce support
grants.''.
SEC. 306. RESEARCH AND RECOMMENDATIONS ON CRIMINAL BACKGROUND CHECK
PROCESS FOR PEER SUPPORT SPECIALISTS.
(a) In General.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary''), in coordination
with the Attorney General, shall develop a report on research and
recommendations with respect to criminal background check processes for
individuals becoming peer support specialists.
(b) Contents.--The report under subsection (a) shall include--
(1) a summary of evidence-based research on the
effectiveness of peer support specialists in improving the
mental health and the substance use disorder recovery of other
individuals;
(2) a survey of each State's laws (including regulations)
that contain criminal background check requirements for serving
as a peer support specialist, including--
(A) an analysis of criminal offenses that are
included in State laws (including regulations) that
prevent individuals from earning a peer support
specialist certification or from practicing as a peer
support specialist;
(B) an analysis of requirements (if any) under the
State plan under title XIX of the Social Security Act
(42 U.S.C. 1396 et seq.) or under a waiver of such plan
relating to background checks for providers
participating under such plan or waiver and the extent
to which any such requirements differ from similar
requirements imposed under State law (including
regulations);
(C) an analysis of requirements (if any) of any
State receiving a grant under part B of title XIX of
the Public Health Service Act (42 U.S.C. 300x et seq.)
relating to background checks for providers
participating in a program under, or otherwise
providing services supported by, such grant;
(D) a review of State laws (including regulations)
that provide exemptions from prohibitions regarding
certification or practice of peer support specialists;
and
(E) an indication of each State that has gone
through the process of amending or otherwise changing
criminal background check laws (including regulations)
for the certification and practice of peer support
specialists; and
(3) recommendations to States on criminal background check
processes that would reduce barriers to becoming certified as
peer support specialists.
(c) Availability.--Not later than 1 year after the date of
enactment of this Act, the Secretary shall--
(1) post the report required under subsection (a) on the
publicly accessible internet website of the Substance Abuse and
Mental Health Services Administration; and
(2) distribute such report to--
(A) State agencies responsible for certification of
peer support specialists;
(B) the Centers for Medicare & Medicaid Services;
(C) State agencies responsible for carrying out a
State plan under title XIX of the Social Security Act
or under a waiver of such plan; and
(D) State agencies responsible for carrying out a
grant under part B of title XIX of the Public Health
Service Act (42 U.S.C. 300x et seq.).
(d) Definition of Peer Support Specialist.--
(1) In general.--In this section, the term ``peer support
specialist'' means an individual--
(A)(i) who has lived experience of recovery from a
mental health condition or substance use disorder and
who specializes in supporting individuals with mental
health conditions or substance use disorders; or
(ii) who has lived experience as a parent or
caregiver of an individual with a mental health
condition or substance use disorder and who specializes
in supporting families navigating mental health or
substance use service systems; and
(B) who is certified as qualified to furnish peer
support services, as described in paragraph (2), under
a process that is determined by the State in which such
individual furnishes such services or determined
appropriate by the Secretary.
(2) Peer support services.--The services described in this
paragraph shall be consistent with the National Practice
Guidelines for Peer Supporters issued by the National
Association of Peer Supporters (or a successor publication) and
inclusive of the Core Competencies for Peer Workers in
Behavioral Health Services of the Substance Abuse and Mental
Health Services Administration.
SEC. 307. OFFICE OF RECOVERY.
(a) In General.--There is established, within the Substance Abuse
and Mental Health Services Administration, an Office of Recovery
(referred to in this section as the ``Office'').
(b) Responsibilities.--The Office shall, taking into account the
perspectives of individuals with demonstrated experience in mental
health or substance use disorder recovery--
(1) identify new and emerging challenges related to the
provision of recovery support services;
(2) support technical assistance, data analysis, and
evaluation functions in order to assist States, local
governmental entities, Indian Tribes, and Tribal organizations
in implementing and strengthening recovery support services,
consistent with the needs of such States, local governmental
entities, Indian Tribes, and Tribal organizations; and
(3) ensure coordination of efforts to identify,
disseminate, and evaluate best practices related to--
(A) improving the capacity of, and access to,
recovery support services; and
(B) supporting the training, education,
professional development, and retention of peer support
specialists.
(c) Report.--Not later than 4 years after the date of enactment of
this Act, the Assistant Secretary for Mental Health and Substance Use
shall submit to the Committee on Health, Education, Labor, and Pensions
of the Senate and the Committee on Energy and Commerce of the House of
Representatives a report on the activities conducted by the Office,
including--
(1) a description of the specific roles and
responsibilities of the Office;
(2) a description of the relationship between the Office
and other relevant components or programs of the Substance
Abuse and Mental Health Services Administration;
(3) the identification of any gaps in the activities of the
Substance Abuse and Mental Health Services Administration or
challenges in coordination between the Office and such relevant
components or programs of such agency; and
(4) recommendations related to the continued operations of
the Office.
SEC. 308. REVIEW OF GRANTS.GOV.
(a) In General.--Not later than 1 year after the date of enactment
of this Act, the Secretary of Health and Human Services (referred to in
this section as the ``Secretary'') shall convene a public meeting for
purposes of improving awareness of, and access to, information related
to current and future Federal funding opportunities, including Federal
funding opportunities related to mental health and substance use
disorder programs.
(b) Topics.--The public meeting under subsection (a) shall
include--
(1) opportunities to improve the utility and functionality
of relevant internet websites maintained by the Secretary, such
as Grants.gov;
(2) other models for displaying and disseminating
information related to Federal funding opportunities, such as
interactive dashboards; and
(3) strategies to improve the ability of entities to apply
for Federal funding opportunities, including entities that have
not traditionally applied for programs administered by the
Secretary.
(c) Website Improvements.--The Secretary shall implement
improvements to Grants.gov based on stakeholder feedback received at
the public meeting under subsection (a).
(d) Report.--Not later than 1 year after the date on which the
public meeting under subsection (a) is convened, the Secretary shall
submit to the Committee on Health, Education, Labor, and Pensions of
the Senate and the Committee on Energy and Commerce of the House of
Representatives a report summarizing the findings of such meeting,
including how the Secretary has taken into account the feedback
received through such meeting and implemented improvements to relevant
internet websites maintained by the Secretary and strategies to improve
awareness of Federal funding opportunities.
TITLE IV--TECHNICAL AMENDMENTS
SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO AN
ADMINISTERING PRACTITIONER.
Section 309A(a) of the Controlled Substances Act (21 U.S.C.
829a(a)) is amended by striking paragraph (2) and inserting the
following:
``(2) the controlled substance is a drug in schedule III,
IV, or V to be administered--
``(A) by injection or implantation for the purpose
of maintenance or detoxification treatment; or
``(B) intranasally, subject to risk evaluation and
mitigation strategy pursuant to section 505-1 of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355-1),
with post-administration monitoring by a health care
professional;''.
SEC. 402. TECHNICAL CORRECTION ON CONTROLLED SUBSTANCES DISPENSING.
Effective as if included in the enactment of Public Law 117-328--
(1) section 1252(a) of division FF of Public Law 117-328
(136 Stat. 5681) is amended, in the matter being inserted into
section 302(e) of the Controlled Substances Act, by striking
``303(g)'' and inserting ``303(h)'';
(2) section 1262 of division FF of Public Law 117-328 (136
Stat. 5681) is amended--
(A) in subsection (a)--
(i) in the matter preceding paragraph (1),
by striking ``303(g)'' and inserting
``303(h)'';
(ii) in the matter being stricken by
subsection (a)(2), by striking ``(g)(1)'' and
inserting ``(h)(1)''; and
(iii) in the matter being inserted by
subsection (a)(2), by striking ``(g)
Practitioners'' and inserting ``(h)
Practitioners''; and
(B) in subsection (b)--
(i) in the matter being stricken by
paragraph (1), by striking ``303(g)(1)'' and
inserting ``303(h)(1)'';
(ii) in the matter being inserted by
paragraph (1), by striking ``303(g)'' and
inserting ``303(h)'';
(iii) in the matter being stricken by
paragraph (2)(A), by striking ``303(g)(2)'' and
inserting ``303(h)(2)'';
(iv) in the matter being stricken by
paragraph (3), by striking ``303(g)(2)(B)'' and
inserting ``303(h)(2)(B)'';
(v) in the matter being stricken by
paragraph (5), by striking ``303(g)'' and
inserting ``303(h)''; and
(vi) in the matter being stricken by
paragraph (6), by striking ``303(g)'' and
inserting ``303(h)''; and
(3) section 1263(b) of division FF of Public Law 117-328
(136 Stat. 5685) is amended--
(A) by striking ``303(g)(2)'' and inserting
``303(h)(2)''; and
(B) by striking ``(21 U.S.C. 823(g)(2))'' and
inserting ``(21 U.S.C. 823(h)(2))''.
SEC. 403. REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED SUBSTANCES.
(a) In General.--Section 303 of the Controlled Substances Act (21
U.S.C. 823) is amended--
(1) by redesignating the second subsection designated as
subsection (l) as subsection (m); and
(2) in subsection (m)(1), as so redesignated--
(A) in subparagraph (A)--
(i) in clause (iv)--
(I) in subclause (I)--
(aa) by inserting ``the
American Academy of Family
Physicians, the American
Podiatric Medical Association,
the Academy of General
Dentistry, the American
Optometric Association,''
before ``or any other
organization'';
(bb) by striking ``or the
Commission'' and inserting
``the Commission''; and
(cc) by inserting ``, or
the Council on Podiatric
Medical Education'' before the
semicolon at the end; and
(II) in subclause (III), by
inserting ``or the American Academy of
Family Physicians'' after
``Association''; and
(ii) in clause (v), in the matter preceding
subclause (I)--
(I) by striking ``osteopathic
medicine, dental surgery'' and
inserting ``osteopathic medicine,
podiatric medicine, dental surgery'';
and
(II) by striking ``or dental
medicine curriculum'' and inserting
``or dental or podiatric medicine
curriculum''; and
(B) in subparagraph (B)--
(i) in clause (i)--
(I) by inserting ``the American
Pharmacists Association, the
Accreditation Council on Pharmacy
Education, the American Psychiatric
Nurses Association, the American
Academy of Nursing, the American
Academy of Family Physicians,'' before
``or any other organization''; and
(II) by inserting ``, the American
Academy of Family Physicians,'' before
``or the Accreditation Council''; and
(ii) in clause (ii)--
(I) by striking ``or accredited
school'' and inserting ``, an
accredited school''; and
(II) by inserting ``, or an
accredited school of pharmacy'' before
``in the United States''.
(b) Effective Date.--The amendment made by subsection (a) shall
take effect as if enacted on December 29, 2022.
Calendar No. 319
118th CONGRESS
2d Session
S. 3393
_______________________________________________________________________
A BILL
To reauthorize the SUPPORT for Patients and Communities Act, and for
other purposes.
_______________________________________________________________________
February 1, 2024
Reported with an amendment